On the origins and diagnosis of asperger syndrome : a clinical, neuroimaging and genetic study by Nieminen-von Wendt, Taina
ON THE ORIGINS AND DIAGNOSIS OF ASPERGER 
SYNDROME 
 A CLINICAL, NEUROIMAGING AND GENETIC STUDY
Taina Nieminen-von Wendt 
ACADEMIC DISSERTATION 
To be presented, with the permission of the Medical Faculty of the University of Helsinki, for 
public examination in Lecture Hall 3 of Biomedicum Helsinki, Haartmaninkatu 8, on 3 December 
2004, at 12 noon
Supervised by: 
Lennart von Wendt MD, PhD, Professor 
Department of Child Neurology, University of Helsinki 
Helsinki, Finland 
Raija Vanhala MD, PhD 
Department of Child Neurology, University of Helsinki 
Helsinki, Finland 
Reviewed by: 
Matti Iivanainen MD, PhD, Professor 
Department of Child Neurology, University of Helsinki 
Helsinki, Finland 
Jari Tiihonen MD, PhD, Professor  
Department of Forensic Psychiatry, University of Kuopio 
Niuvanniemi-Hospital
Kuopio, Finland 
Department of Psychiatry, University of Helsinki 
Helsinki, Finland 
Official examiner at the dissertation appointed by the Faculty of Medicine, 
University of Helsinki: 
Ola Skjeldal MD, PhD, Professor 
Department of Pediatrics, University of Oslo 
Rikshospitalet
Oslo, Norway 
ISBN 952-91-7800-X (nid.) 
ISBN 952-10-2079-2 (PDF) 
Yliopistopaino
Helsinki 2004 
CONTENTS
1. LIST OF ORIGINAL PUBLICATIONS    5 
2. ABBREVIATIONS     6 
3. ABSTRACT      7 
4. INTRODUCTION      8 
   
5. REVIEW OF THE LITERATURE    10 
     5.1 HISTORY      10 
     5.2 EPIDEMIOLOGY     11    
     5.3 DIAGNOSIS      13
5.3.1 INTERNATIONAL CLASSIFICATION OF DISEASES  
         (10TH ED) (ICD-10) AND DIAGNOSTIC AND STATISTICAL  
         MANUAL OF MENTAL DISORDERS (4TH ED) (DSM-IV) 13 
           5.3.2 FORMER DIAGNOSTIC CRITERIA   19 
      5.3.3 SCREENING INSTRUMENTS    21 
5.3.4 OTHER DIAGNOSTIC TOOLS    21 
     5.4 DIFFERENTIAL DIAGNOSTICS AND CO-MORBIDITY  22 
5.4.1 HIGH FUNCTIONING AUTISM    22 
  5.4.2 SCHIZOPHRENIA, SCHIZOID- AND SCHIZOTYPAL
         PERSONALITY DISORDER    25 
5.4.3 ATTENTION - DEFICIT HYPERACTIVITY DISORDER  29 
5.4.4 TICS and TOURETTE SYNDROME   30 
 5.4.5 EATING DISORDERS    30 
 5.4.6 ALEXITHYMIA     31 
 5.4.7 OBSESSIVE-COMPULSIVE DISORDER   31 
 5.4.8 MUTISM     32 
5.5 NEUROIMAGING     32  
           5.5.1 MRI      32 
           5.5.2 SPECT, PET, fMRI, and NMR    34 
5.6 GENETICS      36 
6. AIMS OF THE STUDY     39 
7. SERIES       40 
     7.1 THE CLINICAL STUDY     41 
     7.2 THE MRI STUDY     41 
     7.3 THE PET STUDIES     42 
     7.4 THE GENETIC STUDY     42 
8. ETHICAL ASPECTS     45  
9. METHODS      46 
     9.1 DIAGNOSTIC PROCEDURES    46 
9.1.1 THE CLINICAL STUDY    46 
 9.1.2 THE MRI STUDY     46 
9.1.3 THE PET STUDIES     47 
 9.1.4 THE GENETIC STUDY    47 
     9.2 NEUROPSYCHOLOGICAL METHODS    47  
 9.2.1 THE MRI STUDY     47 
9.2.2 THE PET STUDIES     47 
9.3 NEUROIMAGING METHODS    48 
9.3.1 MRI      48 
              9.3.2 THEORY OF MIND – PET STUDY   48
9.3.3 DOPAMINE - PET STUDY    51  
9.4 GENETICS      52  
9.4.1 LABORATORY METHODS    52 
 9.4.2 STATISTICAL ANALYSES    52
10. RESULTS      54  
       10.1 CLINICAL FINDINGS     54 
       10.2 NEUROIMAGING FINDINGS    55 
 10.2.1 MRI - STUDY     55 
 10.2.2 PET - STUDIES     56 
10.3 GENETICS      57
11. DISCUSSION      59  
       11.1 METHODOLOGICAL CONSIDERATIONS   59 
11.1.1 CLINICAL STUDY    59  
11.1.2 NEUROIMAGING STUDIES    60 
 11.1.3 MOLECULAR GENETIC STUDY   61 
       11.2 THE DIAGNOSTIC CRITERIA FOR THE CLINICAL ENTITY OF    
               ASPERGER - SYNDROME– NEED FOR REVISION?  61 
 11.2.1 ROLE OF CLINICAL SYMPTOMS AND SIGNS NOT  
                                 INCLUDED IN THE ICD-10 AND DSM-IV   62 
       11.3 NEUROIMAGING STUDIES    64 
 11.3.1 MRI STUDY     64 
11.3.2 THEORY OF MIND–PET STUDY   66 
11.3.3 DOPAMINE-PET STUDY    70  
       11.4 MOLECULAR GENETIC STUDY    71 
12. VIEWPOINTS      73  
13. CONCLUSIONS      75  
14. ACKNOWLEDGEMENTS     76 
15. LIST OF REFERENCES     79  
Appendix 1. THE COMPLEMENTARY QUESTIONS REGARDING SYMPTOMS AND 
SIGNS NOT INCLUDED IN THE ICD-10 AND/OR DSM-IV.
 5 
1. LIST OF ORIGINAL PUBLICATIONS 
This thesis is based on following papers, which will be referred to in the text by their Roman 
numerals I-V. 
I. Nieminen-von Wendt T, Paavonen EJ, Ylisaukko-oja T, Sarenius S, Källman T, Järvelä I, von 
Wendt L: Occurrence of prosopagnosia, abnormal sensibility, sleep disorders in non-AS and AS 
individuals in families with Asperger syndrome. Submitted
II. Nieminen-von Wendt T, Salonen O, Vanhala R, Kulomäki T, von Wendt L, Autti T: A 
quantitative controlled MRI study of the brain in 28 persons with Asperger Syndrome. Int J 
Circumpolar Health 2002; 61 suppl 2,22-35 
III. Nieminen-von Wendt T, Metsähonkala L, Kulomäki T, Aalto S, Autti T, Vanhala R, von 
Wendt L: Changes in cerebral blood flow in Asperger syndrome during theory of mind tasks 
presented by the auditory route. Eur J Child Adol Psych 2003; 12(4): 178-189
IV. Nieminen-von Wendt T, Metsähonkala L, Kulomäki T, Aalto S, Autti T, Vanhala R, Eskola O, 
Bergman J, Hietala J, von Wendt L: Increased presynaptic dopamine function in Asperger 
syndrome. NeuroReport 2004; 15(5): 757-760
V. Ylisaukko-oja T, Nieminen-von Wendt T, Kempas E, Sarenius S, Varilo T, von Wendt L,
Peltonen L, Järvelä I: Genome-wide scan loci of Asperger syndrome. Mol Psychiatry 2004; 9: 161-
168
 6 
2. ABBREVIATIONS  
ADHD Attention Deficit Hyperactivity Disorder 
ADI-R Autism Diagnostic Interview Revised 
ADOS Autism Diagnostic Observation Schedule 
APA American Psychiatric Association 
AS Asperger Syndrome 
ASDI Asperger Syndrome Diagnostic Interview 
ASSQ Asperger Syndrome Screening Questionnaire 
BA Brodmann’s area 
CARS Childhood Autism Rating Scale  
CBF Cerebral blood flow  
cM centiMorgan   
gCBF Global cerebral blood flow 
rCSF Regional cerebral blood flow 
DNA Deoxyribonucleic acid 
DSM-III-R Diagnostic and Statistical manual 3 rd edition revised 
DSM-IV Diagnostic and Statistical Manual of Mental Disorders 
FDOPA         6-[18F]fluoro-L-DOPA 
HFA High functioning autism 
FMRI Functional magnetic resonance imaging 
ICD-10 International Classification of Diseases, 10th edition 
IMGSAC International Molecular Genetic Study of Autism Consortium 
IQ Intelligence quotient 
Ki FDOPA uptake rate constant 
LC Liability class 
LD Linkage disequilibrium 
LOD Logarithm of odds 
MLS Multipoint lod score 
MRI Magnetic resonance imaging 
NPL Non-parametric linkage analysis 
OCD Obsessive compulsive disorder 
PCR Polymerase chain reaction 
PDD Pervasive developmental disorder 
PET Positron emission tomography 
PHYS Physical stories 
ROI Region of interest 
SANS Schedule for Negative Symptoms 
SAPS Schedule for Positive Symptoms 
SCID Structured Clinical Interview  
SD Standard deviation 
SN Substantia nigra  
SNc Substantia nigra - pars compacta 
SNr Substantia nigra - pars reticulate  
SPECT Single photon emission computed tomography  
SPM Statistical parametric mapping 
TOM Theory of mind 
WHO World Health Organisation 
VOI Volume of interest 
 7 
3. ABSTRACT 
Originally described in 1944, Asperger syndrome was generally acknowledged as a separate 
clinical entity by being included in the official diagnostic classifications, the ICD-10 in 1993 and 
the DSM-IV in 1994. Asperger syndrome belongs to the autism spectrum of disorders, 
characterised by marked difficulties in socialisation, one-sided communication style, rigid patterns 
of interest typically focused on unusual, intense, and highly circumscribed interests, dependence on 
routines and rituals, and formal and pedantic speech. Studies of prevalence have yielded divergent 
results ranging from 0.3 to 48.4 per 10 000.  
The aim of this study was to check the diagnostic criteria and clarify the etiopathogenesis of 
Asperger syndrome using an integrated effort by clinical, neuroimaging and molecular genetic 
research units. In all, 163 persons with Asperger syndrome were recruited for the present clinical, 
neuroimaging and genetic studies.  
The clinical series consisted of 29 families, 58 persons with Asperger syndrome, age range 3 – 92 
years, in which AS was present in at least two generations. These families were recruited through 
the Hospital for Children and Adolescents, Department of Child Neurology, Helsinki University 
Central Hospital (HUCH), and the Helsinki Asperger Center (HAC), Medical Center Dextra, 
Helsinki, Finland. The diagnosis of Asperger syndrome was based on the criteria in the ICD-10 and 
DSM-IV and, in addition, screening and appropriate diagnostic instruments were used.  
The clinical study indicated that new clinical traits not reported previously are over-represented in 
individuals representing Asperger syndrome. These traits were sensory integration problems, 
prosopagnosia, aberrant eating habits and sleeping problems. The inclusion of these traits in the 
revised versions of the diagnostic manual of the ICD-10 and DSM-IV is suggested. 
The MRI study revealed a reduced midsagittal diameter of the mesencephalon in the Asperger 
group.  
The PET study using a Theory of Mind-based auditory stimulus revealed an overall increase in the 
activation of the cerebellum in subjects with Asperger syndrome. The [18F]FDOPA - PET study 
revealed a hyperdopaminergic state in both the striatum and the frontal cortex, with the absence of 
an asymmetric uptake. The SPM analysis confirmed this finding for the striatum but also disclosed 
large clusters located in the medial frontal cortex, the left inferior frontal gyrus and the right 
superior frontal gyrus. An increase in Ki for [18F]FDOPA in the subjects with AS as compared to 
the controls was also revealed.  
The molecular genetics study revealed that Asperger syndrome is enriched in some families, but 
the exact mode of inheritance remained obscure. There was an overlap of chromosomal regions in 
chromosome 1 for schizophrenia and in chromosome 3 for autism. 
On a general level, this set of studies revealed partly overlapping clinical, neuroimaging and 
molecular genetic findings, in particular with autism and schizophrenia. These findings, which are 
also supported by some other studies, may indicate that a number of neuropsychiatric disorders, 
such as autism spectrum disorders, schizophrenia, attention deficit hyperactivity disorder, 
obsessive compulsive disorder, Tourette syndrome and anorexia nervosa, may represent the same 
family of disorders, sharing in a variable manner a joint set of neurobiological and 
neurobehavioural substrates.  
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4.  INTRODUCTION
Hans Asperger first described the syndrome named after him in 1944 (Asperger 1944). Impairment 
in social interaction, dependence on routines and rituals, formal and pedantic speech and interests 
in unusual and odd hobbies characterise Asperger syndrome (AS). At present, the diagnosis of 
Asperger syndrome is based on sets of criteria incorporated in the DSM-IV (Diagnostic and 
Statistical Manual of Mental Disorders, American Psychiatric Association; APA 1994) and the 
ICD-10 (International Classification of Disease; World Health Organisation; WHO 1993) 
classification. The inclusion criteria for a diagnosis in the ICD-10 (WHO 1993) are qualitative 
abnormalities in reciprocal social interactions and restricted repetitive and stereotyped patterns of 
behaviour, interests and activities. The exclusion criteria are a clinically-significant general delay 
in social and occupational areas of functioning. It also requires the exclusion of childhood-onset 
schizophrenia. In his set of criteria, Gillberg (1989) also included motor clumsiness, which is not 
an essential criterion in the ICD-10 (WHO 1993) or DSM-IV (APA 1994). Asperger syndrome has 
been generally regarded as part of the autism spectrum of disorders. The prevalence of Asperger 
syndrome was reported to be 4-7/1,000 in the group of 7- to 16-year-olds in western Sweden 
(Ehlers and Gillberg 1993).  
Asperger syndrome made a late appearance in Finland, as the first diagnosis was apparently made 
in 1989 at the unit for autism at the Department of Child Neurology, Helsinki University Central 
Hospital, at Children’s Castle in Helsinki, Finland. The importance and impact of this condition, 
however, remained unknown to both professionals and lay people until the latter part of the 
1990s´s. In 1998, the partly autobiographical book Marius’ story by Liisa Ruefenacht was 
published. The vivid case description captured the minds of a large public and rapidly provoked 
major interest in this syndrome. This piece of literature apparently had a far greater impact on 
public opinion and general attitudes in society than numerous lectures given by expert 
professionals. Many readers of the book recognised features of Marius in family members who, 
despite excellent academic skills, had turned out to be losers in modern Finnish society.  
Lay people suspecting that Asperger syndrome is the cause of their own or their relatives' social 
and other shortcomings started to ask for diagnostic and counselling services from the health 
service, which was poorly prepared to cope with these new demands. The availability of diagnostic 
services, counselling, rehabilitation, support for studying at secondary school or even at university 
level has developed in recent years, but it is still very unevenly distributed over the country. The 
advent of this “new” diagnostic category triggered a demand for appropriately tailored services but 
also led to the opposite effect, as the justification of Asperger syndrome as a separate clinical entity 
was questioned, not only by researchers in the field of contact disorders. These controversies are 
easily understandable, as many clinical features of Asperger syndrome are also encountered in 
many other disorders, which could most conveniently be labelled as being neuropsychiatric. It is 
therefore evident that an individual fulfilling the criteria for Asperger syndrome can also be 
described using a combination of diagnoses established much earlier. These diagnoses include 
social phobia, obsessive-compulsive disorder, alexithymia and schizophrenia. In this context, it is 
necessary to remember that the contemporary set of neuropsychiatric diagnoses incorporated in the 
ICD-10 or DSM-IV is non-systematic in the sense that the classification does not follow any pre-
determined theoretical framework but is a result of continuing development. This implies that the 
diagnostic categories do not necessarily total exclude each other. The correctness of a specific 
neuropsychiatric diagnosis therefore appears to be somewhat relative.  
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On the other hand, a correct diagnosis may be of major importance for the subsequent management 
of the patient, as the principles of treatment may differ considerably, depending on the aetiology 
which is thought to be related to the specific diagnosis. In the case of aetiology, one essential 
watershed is the question of the role of inherited components vs. environmental ones. In Asperger 
syndrome, as in many other neuropsychiatric disorders, there is currently ample evidence of the 
existence of inherited traits, or more accurately forerunners of personality features which may 
manifest themselves as clinical traits. These observations may tempt people to make a simplified 
dichotomous classification of neuropsychiatric disorders as being either inherited or caused by 
adverse environmental factors, which often appear during early development. An interpretation of 
this kind is not warranted by any scientific studies.  
It seems plausible to assume that the Asperger personality or the manifest clinical appearance of 
the syndrome is a consequence of one or several combinations of one or several sets of inherited 
components, which manifest themselves in certain external conditions. A role of this type for 
environmental factors in multiplex neuropsychiatric disorders in general is also supported by the 
fact that the human genome consists of approximately 30,000 genes. The number of neurons totals 
around 100 billion and every neuron has many connections. In multiplex neuropsychiatric 
disorders involving many areas, it is not possible for the relatively few genes to determine in detail 
all the related processes. The question of the extent to which inherited factors play a role is 
therefore not especially meaningful. A far more fruitful scientific approach is to define the 
endophenotypes and the underlying neurobiological features, functions and structures as 
meticulously as possible. This is also of importance due to the fact that, in the interaction between 
genetically determined components and environment, there is the optimal therapeutic window. A 
more in-depth knowledge of the pathogenesis of Asperger syndrome and related disorders can be 
expected to create a scientific basis for intervention, as soon as alarming symptoms and signs occur 
or can be anticipated in families at risk of developing these disorders. 
The present thesis describes clinical, neuroimaging and genetic investigations into the diagnosis 
and aetiology of Asperger syndrome. It is hoped that the results will arouse interest in this type of 
research and encourage other research workers to investigate large populations of Asperger 
syndrome elsewhere.  
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5. REVIEW OF THE LITERATURE 
5.1 HISTORY
Hans Asperger (1906-1980), an Austrian paediatrician, was the first scientist to describe Asperger 
syndrome (AS) when, in 1944, he published the paper entitled “Die Autistischen Psychopathen im 
Kindesalter” (Autistic Psychopathy in Childhood) (Asperger 1944). Although Asperger had 
described the syndrome that was subsequently given his name, Eva Ssucharewa, a Russian 
scientific assistant in neurology, wrote a paper back in 1926 in which she described boys with what 
she called "schizoid personality disorder" (Ssucharewa and Wolff 1996). As a matter of fact, the 
boys she described were indistinguishable from the condition which Hans Asperger called "autistic 
psychopathy" in his case studies. 
Unaware of Leo Kanner’s description of 11 children with autistic disturbances of affective contact, 
communication problems and unusual responses to the inanimate environment (Kanner 1943) 
published a year earlier, Hans Asperger described four boys, aged six to 11, with unusual interests 
and odd social behaviour. These boys had preserved intellectual skills but displayed oddness in 
non-verbal communication, difficulty understanding social cues, poor empathy and a tendency to 
intellectualise emotions, formalistic speech, all-absorbing egocentric preoccupations with unusual 
and circumscribed interests and motor clumsiness with odd posture and gait. Asperger described 
these boys as “little professors” who talked about their own interests but had difficulties with non-
verbal and pragmatic aspects of communication, such as difficulty understanding other people's 
facial expressions. Asperger also pinpointed aggression and other conduct problems in these boys 
as a result of their behavioural difficulties, including non-compliance and negativism. Their 
shortcomings often stemmed from poor social understanding, difficulties in peer relations and 
egocentrism. Asperger’s original paper also emphasised that the personality traits were primarily 
male transmitted (Asperger 1944).  
The term autism was created by Bleuler in 1916 to describe “a loss of contact, a retirement into self 
and a disregard of the outside world” observed in schizophrenia (Bleuler 1916). Hans Asperger, in 
terming the condition “autistic personality disorder”, used the word autism, but distinguished the 
condition he described from schizophrenia by emphasising the earlier onset of autistic personality 
disorder, usually after three years of age (Asperger 1944).  
Asperger’s work, originally published in German, became widely known to English-speaking 
readers in 1981, when Wing published a review of Asperger’s work and a series of cases (n=30) 
displaying symptoms similar to those Asperger had described. She highlighted the possible 
continuities with autism and located the disorder in the autistic spectrum (Wing 1981). Wing’s 
(1981) description markedly increased interest in this condition and was the impetus for 
forthcoming studies of Asperger syndrome. 
Although Asperger syndrome was originally described back in 1944, it was not included in the 
ICD-10 (International Classification of Disease; World Health Organisation; WHO 1993) and the 
DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric 
Association; APA 1994) until almost 50 years later. Today, AS is defined according to the ICD-10 
(WHO 1993) and the DSM-IV (APA 1994) as being characterised by qualitative impairments in 
social interaction, restricted, repetitive and stereotyped patterns of behaviour, interests and 
activities and normal cognitive and language development.  
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 5.2 EPIDEMIOLOGY  
There are only a few epidemiological studies of AS. There are seven studies of autism and 
pervasive developmental disorders (PDD) and six surveys provide specific estimates of the 
prevalence of AS, alongside estimates of other subtypes of PDD (Sponheim and Skjeldal 1998, 
Taylor et al. 1999, Kadesjö et al. 1999, Baird et al. 2000, Powell et al. 2000, Chakrabarti and 
Fombonne 2001). There is only one study which has investigated AS prevalence exclusively, 
without taking other pervasive developmental disorders into account (Ehlers and Gillberg 1993). In 
this population-based study conducted in Sweden by Ehlers and Gillberg (1993) in the first 
systematic inquiry into AS, 1,519 children attending five mainstream schools, aged 7-16 years, 
were included in the screening stage. The screening instrument was a 27-item screening 
questionnaire for Asperger syndrome (ASSQ), which was filled in by the child's teacher  when 
he/she attended his/her class. Of these pupils, the 18 individuals who exceeded the cut-off point of 
five points in the ASSQ were selected for further investigation. The second phase of the 
investigation involved a mixture of a direct assessment of the child, parental interviews, direct 
observation and teacher interviews. Of 14 children participating in this stage, four definite cases of 
AS according to the ICD-10 were identified, giving a prevalence rate of 28.5 per 10,000. When 
using the criteria developed by Gillberg and Gillberg (1989) – and further elaborated by Gillberg in 
1991 – a prevalence of 3.6 per 1,000 was noted (Ehlers and Gillberg 1993). The study has been 
criticised for having too small a target population; for lacking details about school selection, 
sampling procedures and no rationalisation of why the prevalence of AS was studied in the selected 
neighbourhood. Limited evidence was also given about the psychometric properties of the 
screening questionnaires and the procedures that were followed to select subjects for further 
assessments were not entirely clear. Despite the fact that the confidence in teachers' reports as the 
sole informants was emphasised, the parents contributed far more to the final diagnosis than the 
teachers’ reports and interviews. Lastly, the prevalence varied depending on the specific diagnostic 
criteria that were used and this has raised questions about the overall validity of the case 
determination (Fombonne and Tidmarsh 2003). 
Further information derives from epidemiological surveys that have simultaneously assessed the 
presence of autistic disorder and AS. All six have been carried out in Europe; in countries where 
there is vast experience of performing population-based surveys of child health. In all but one 
study, the sample size (>15,000) was appropriate for the target population. 
In a Norwegian survey carried out in 1998 on a target population of 65,688 with an age span from 
three to14 years, the children were screened with a screening schedule of 10 items and with an 
intensive assessment consisting of a parental interview + direct observation, the Childhood Autism 
Rating Scale (CARS) (Schopler et al. 1980) and the Autistic Behaviour Checklist (ABC) (Wadden 
et al. 1991). The diagnosis was set according to the ICD-10 and the prevalence of AS was found to 
be 0.3/10,000 (Sponheim and Skjeldal 1998). 
In mid-1998, in the United Kingdom, Taylor and co-workers (1999) identified children with 
autistic disorders born since 1979, in a population-based study in eight health districts. The study 
population consisted of 490,000 children. The screening instruments were the computerised special 
needs/disability register at centres for disease control and prevention (CDC) and the records from 
special schools. The instruments used for intensive assessment rated all the data available in the 
children’s records. The diagnosis set according to the ICD-10 yielded 71 cases of AS, which gave a 
prevalence of 1.4 per 10,000 (Taylor et al. 1999). 
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In the study by Kadesjö et al. (1999), the sample consisted of 826 children, aged 7, of whom four 
met the criteria for AS, yielding a prevalence of 48.4 per 10,000. The screening consisted of letters 
to professionals to identify children with autistic conditions + direct assessments and a parental 
interview. The intensive assessment included the ADI-R (Autism Diagnostic Interview Revised), 
ASSQ and WISC (Wechsler Intelligence Scale for Children). The diagnostic criteria included the 
DSM-III-R/ICD-10 and Gillberg’s criteria (Kadesjö et al. 1999). Criticism of this study has 
pinpointed the sample size, which is regarded as extremely small (Fombonne and Tidmarsh 2003). 
Even though the prevalence estimates are high, no robust inference can be made from the survey, 
because of the wide confidence intervals indicating the lack of precision of these estimates 
(Fombonne 2001).  
The incidence of childhood autism and other autistic-spectrum disorders (ASD) in preschool 
children was determined for two areas of the West Midlands in the UK for the time period 1991-
1996 by Powell and co-workers in 2000, on the basis of a study population of 25,377 children. 
Children diagnosed before the age of five and residing within the study areas at the time of the 
diagnosis were identified in the records of four child development centres. The intensive 
assessment included the ADI-R and the diagnosis was made according to the DSM-IIIR, DSM-IV 
and ICD-10 criteria. The incidence rate per 10,000 children per year for the combined areas was 
8.3 for all children with autism spectrum disorders, 3.5 for classical childhood autism and 4.8 for 
other autism spectrum disorders (Powell et al. 2000).
In the study by Baird and co-workers (2000) in United Kingdom, 16,235 children aged 18 months 
were screened using the Checklist for Autism in Toddlers (CHAT) in order to identify childhood 
autism. Two further screening procedures were conducted at age three and five and the population 
was followed up at age seven. Before setting a diagnosis according to the ICD-10 and DSM-IV, 
ADI-R psychometrics were used. Five cases with AS were found and the prevalence was 3.1 per 
10,000 (Baird et al. 2000). 
The survey by Chakrabarti and Fombonne (2001) in the UK comprised 15,500 children aged 2.5 to 
6.5 years. Children with symptoms suggestive of a PDD were intensively assessed by a 
multidisciplinary team, which conducted standardised diagnostic interviews and administered 
psychometric tests. The prevalence of AS was 8.4 per 10,000 (13 cases). The diagnosis was set 
according to the ICD-10 and DSM-IV after the ADI-R, WPPSI (Wechsler Preschool and Primary 
Scales of Intelligence) (Wechsler 1967) and Merrill-Palmer multidisciplinary assessment had been 
carried out (Chakrabarti and Fombonne 2001). 
When reviewing the epidemiological studies made of AS, it is striking that the prevalence rates 
range from 0.3 to 48.4 per 10,000. This huge variation reflects the methodological differences 
across the studies (Fombonne 2001, Fombonne and Tidmarsh 2003). The true prevalence of AS is 
therefore difficult to estimate. According to Fombonne and Tidmarsh (2003), a conservative 
prevalence estimate of children with autistic disorder would give a figure of 10 per 10,000. The six 
surveys suggest that the prevalence of AS might be about two per 10,000. To obtain more valid 
estimates, it will be important to focus epidemiological studies on older groups of children. In the 
six surveys, the mean age of the samples was five to eight years. In order to obtain more valid 
estimates, it will be important to focus on rates applying to slightly older age groups (i.e. children 
aged 8-12 years), since children with AS are identified and diagnosed much later than children with 
typical autism and, as a result, estimates obtained in younger samples might underestimate the 
prevalence of AS syndrome. For this reason, these studies probably do not provide correct 
information about the epidemiological situation, as AS is usually diagnosed later in life. By and 
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large, improvements in the diagnostic criteria and increased precision in the diagnostic tools can be 
expected to improve the quality of forthcoming epidemiological studies.  
5.3. DIAGNOSIS 
5.3.1 INTERNATIONAL CLASSIFICATION OF DISEASES (10TH ED) (ICD-10) 
          AND DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS     
         (4TH ED) (DSM-IV) 
Public and scientific interest in AS started in 1980ies, but AS was not incorporated in the 
international diagnostic system, the ICD-10 (WHO 1993), until 1993 (Table 1) and the DSM-IV 
(APA 1994) diagnostic system, used in the United States until 1994 (Table 2).  
Common to both diagnostic classifications is the fact that AS requires qualitative impairment in 
social interaction, restricted repetitive and stereotyped patterns of behaviour, interes ts and activities 
and no lack of any clinically-significant general delay in language or cognitive development.  
Table 1. Research diagnostic criteria for Asperger syndrome (ICD-10) (WHO 1993) 
A. There is no clinically significant general delay in spoken or receptive language or cognitive development. 
Diagnosis requires that single words should have developed by two years of age or earlier and that 
communicative phrases be used by three years of age or earlier. Self-help skills, adaptive behaviour and 
curiosity about the environment during the first three years should be at a level consistent with normal 
intellectual development. However, motor milestones may be somewhat delayed and motor clumsiness is usual 
(although not a necessary feature). Isolated special skills, often related to abnormal preoccupations, are 
common, but are not required for diagnosis. 
B. There are qualitative impairments in reciprocal social interaction (criteria as for autism). Diagnosis requires 
demonstrable abnormalities in at least two out of the following four areas: 
1. Failure adequately to use eye-to-eye gaze, facial expression, body posture and gesture to regulate social interaction 
2. Failure to develop (in a manner appropriate to mental age, and despite ample opportunities) peer relationships that  
    involve a mutual sharing of interests, activities and emotions 
3. Lack of socio-emotional reciprocity as shown by an impaired or deviant response to other people's emotions; and/or 
    lack of modulation of behaviour according to social context, and/or a weak integration of social, emotional and    
    communicative behaviours 
4. Lack of spontaneous seeking to share enjoyment, interests or achievements with other people (e.g. a lack of   
   showing, bringing or pointing out to other people objects of interest to the individual)  
.
C. The individual exhibits an unusual intense, circumscribed interest, or restricted, repetitive, and stereotyped 
patterns of behaviour, interests and activities (criteria as for autism; however it would be less usual for these to 
include either motor mannerisms or preoccupations with part-objects or non-functional elements of play 
materials). Diagnosis requires demonstrable abnormalities in at least two out of the following four areas: 
1. An encompassing preoccupation with one ore more stereotyped and restricted patterns of interest that is abnormal  
   in content or focus; or one or more interests that are abnormal in their intensity and circumscribed nature though not      
   in their content or focus 
2. Apparently compulsive adherence to specific, non-functional, routines or rituals 
3. Stereotyped and repetitive motor mannerisms that involve either hand/finger flapping or twisting, or complex whole      
    body movements 
4. Preoccupation with part-objects or non-functional elements of play materials 
D. The disorder is not attributable to other varieties of pervasive developmental disorder; simple schizophrenia 
schizotypal disorder; obsessive compulsive disorder, anakastic personality disorder; reactive and disinhibited 
attachment disorder of childhood. 
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Similarities and dissimilarities between the ICD-10 and DSM-IV 
The DSM-IV states that the criteria must not be met for another specific PDD, or schizophrenia 
(SCH) (APA 1994) (Table 2). Similarly, in the ICD-10, it is also pointed out that AS is not 
attributable to other varieties of PDD, simple schizophrenia, schizotypal disorder; obsessive-
compulsive disorder; anakastic personality disorder; reactive and disinhibited attachment disorder 
of childhood (WHO 1993) (Table 1).  
One major difference between these two diagnostic instruments can be found in the paragraph 
which is only included in the DSM-IV and states that the disturbance must cause clinically-
significant impairments in social, occupational, or other important areas of functioning. This 
difference can be interpreted as indicating that the ICD-10 accepts a diagnosis on less strict criteria 
than the DSM-IV.  
Diagnosis at different ages
The age factor is another important issue, as the traits in AS usually begin to show after three years 
of age and they appear to become worse when starting kindergarten or school; that is when the peer 
relationship starts to be important and difficulties in social communication begin to show. The 
diagnosis of AS in a child is usually made after five years of age (Gillberg 1989). 
Table 2. Diagnostic criteria for Asperger syndrome (DSM-IV) (APA 1994)
A. Qualitative impairment in social interaction, as manifested by at least two of the following: 
1. Marked impairment in the use of multiple nonverbal behaviours such as eye-to-eye gaze, facial expression, body    
    postures, and gestures to regulate social interaction 
2. Failure to develop peer relationships appropriate to developmental level 
3. A lack of spontaneous seeking to share enjoyment, interests or achievements with other people (eg: by a lack of    
   showing, bringing, or pointing out objects of interest to other people) 
4. Lack of social or emotional reciprocity 
B. Restricted repetitive and stereotyped patterns of behaviour, interests, and activities, as manifested by at least 
one of the following: 
1. Encompassing preoccupation with one or more stereotyped and restricted patterns of interest that is abnormal either  
    or focus 
2. Apparently inflexible adherence to specific, non-functional routines or rituals 
3. Stereotyped and repetitive motor mannerisms (eg: hand or finger flapping or twisting, or complex whole-body  
    movements) 
4. Persistent preoccupation with parts of objects 
C. The disturbance causes clinically significant impairment in social, occupational, or other important areas of 
functioning. 
D. There is no clinically significant general delay in language.  
E. There is no clinically significant delay in cognitive development or in the development of age-appropriate 
self-help skills, adaptive behaviour (other than social interaction), and curiosity about the environment in 
childhood. 
F. Criteria are not met for another specific Pervasive Developmental Criteria, or Schizophrenia. 
The traits seen in children with AS are those that persist into adulthood. According to Wing (1981), 
an adult person with AS has a deficiency in non-verbal communication, difficulty recognising 
social cues, odd intonation in the use of voice and strange facial emotions. All these features impair 
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the subjects' social behaviour in everyday life. Their special interests are strange and special, very 
narrow minded, are not shared with others and are performed very obsessively. The motor 
mannerisms give an impression of clumsiness, even though the individual is not truly clumsy but 
has difficulty maintaining posture. Wing (1981) also stated that a person with AS in adulthood 
must already have fulfilled the criteria of AS in childhood or at least have had features of autism. 
This is an important observation, but it makes diagnoses difficult in adulthood whenever the 
information about childhood is incomplete. 
Subtypes 
Wing and Gould (1979) and Wing (1996) subdivided children with autism according to four main 
types of social impairment (‘aloof’, ‘passive’ and ‘active but odd’, ’the over-formal stilted group’) 
(Table 3). The same subdivision can be used for AS with some reservations, as the active but odd 
group in the list by Wing and Gold (1979) has ADHD (attention deficit hyperactivity disorder) as a 
co-morbidity, as the clinical experience appears to show that this is the case also in the AS group. 
In other respects, the sub-classification appears to be the same in both autism and AS, even though 
it is not widely used.  
Table 3. Subdivision in autism according to social impairment, adapted from Wing and 
Gould (1979) and Wing (1996)   
The aloof group
is happy when left alone 
avoids eye gaze, dislikes physical contact, but enjoys rough games 
usually no interest/understanding for other people’s feelings or emotions 
lives in a world of his/her own 
has a high pain threshold 
shows generally little or no interest in other people 
remains isolated and unresponsive as an adult 
The passive group
does not actively avoid contact, but does not initiate it 
makes eye contact when told to 
other children may abuse  
never points out things of interests to others 
The active but odd group
no sense of social barriers 
will talk to anyone 
stares at people instead of eye contact 
physically very demonstrative – inappropriate (lacking in social rules) 
gesture and facial expression may be exaggerated/inappropriate 
desperate to make friends in the wrong way (disrupting games, for example)  
The over-formal stilted group
appears in later adolescents or adults (with higher IQ, good expressive language) 
treats family members as distant strangers 
is polite and formal 
is extremely punctilious about keeping to rules 
gets upset and indignant if anyone infringes the rules 
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Asperger syndrome or infantile autism? 
The criteria for AS in the DSM-IV (APA 1994) are the same as those for autism, with three 
exceptions. First, the communication and imagination impairment criteria for autism are not listed 
for AS. Second, it is claimed that individuals with AS do not suffer from a "clinically significant 
general delay in language" (APA 1994). Third, the child with AS does not have a "clinically 
significant delay in cognitive development or in the development of age-appropriate self-help 
skills, adaptive behaviour (other than in social interaction) and curiosity about the environment in 
childhood" (Eisenmajer 1996, Eisenmajer et al.1996, Volkmar et al. 1998). These criteria are in 
accordance with the thinking of Asperger (1944), who believed that the main handicap was of a 
social nature and not due to intellectual or language delays.  
The inconsistencies in the definitions of AS and autism are related in the principal areas to early 
cognitive, linguistic and motor development (Szatmari et al. 1995, Eisenmajer et al. 1996, Klin and 
Volkmar 1997, Volkmar and Klin 2000, Klin and Volkmar 2003).
Cognitive delay
While some individuals with autism exhibit mental retardation, a person with AS must not, as the 
definitions in the ICD-10 (WHO 1993) and DSM-IV (APA 1994) exclude individuals with a 
"clinically significant general delay in cognitive development”. The ICD-10 (WHO 1993) and 
DSM-IV (APA 1994) do specify what is meant by normal cognitive development  but refer to it in 
a vague way.  What is meant by the words “self-help skills, adaptive behaviour and curiosity about 
the environment during the first three years should be at a level consistent with normal intellectual 
development" is not determined. Even before the official diagnostic criteria (ICD-10 and DSM-IV) 
were accepted, Gillberg and Gillberg (1989) tried to focus on the dilemma of the cognitive delay. 
Their review was based on papers available at that time and highlighted the variable rates of AS. 
They concluded that, among children with normal intelligence, rates of 10-26 per 10,000 children 
were minimum figures. In addition this, another 0.4 per 10,000 Swedish teenagers displayed the 
combination of AS and mild mental retardation (Gillberg and Gillberg 1989). In this context, it 
should be pointed out that Hans Asperger himself focused on individuals with relatively high 
cognitive ability, but he also referred to individuals with considerable intellectual retardation 
(Asperger 1944). 
Language skills
As presently defined in the DSM-IV (APA 1994) and ICD-10 (WHO 1993), the principal sign 
differentiating AS from autism is the comparatively good early language skills in AS (Volkmar et 
al. 1998, Klin and Volkmar 1997, Volkmar and Klin 2000, Klin and Volkmar 2003). The criterion 
included in the ICD-10 (WHO 1993), which requires language development within normal limits, 
is in accordance with Asperger's (1944) original view that children with AS have no delay in 
language. The DSM-IV (APA 1994) does not specify what is meant by normal cognitive language 
development, whereas the ICD-10 (WHO 1993) states that “single words should have developed 
by two years of age or earlier and that communicative phrases be used by three years of age or 
earlier”. 
In a hospital-based study comparing the clinical symptoms of autism and AS by Eisenmajer and 
co-workers (1996), almost half (43%) the AS group of 69 individuals (61 male, 8 female; mean age 
10.7 years; SD 3.6) were reported to have a delayed onset of language. On the basis of this study, it 
became very evident that the clinicians in many cases had not been using a delay in onset of 
language as an exclusion criterion for AS (Eisenmajer et al. 1996). Eisenmajer and co-workers 
(1996) concluded that language delay predicted autistic symptomatology in young children with 
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PDD. This was, however, not the case when the children approached pre-adolescence (average age 
11 years). Another conclusion was that early language delay was not a suitable differentiating 
variable for PDD subtypes.  
One essential shortcoming, which inevitably causes confusion, is the lack of a specific definition in 
the AS and autism diagnostic criteria of abnormal language development. How, for example, does 
a clinician classify a child who develops words and phrases at the normal age but whose 
communicative ability remains limited? Other children may be late in developing words, but their 
speech develops rapidly after this stage. The language definition is also problematic when it comes 
to children who do develop words and phrases by the age of two and three respectively, but 
subsequently display linguistic delay. The communication variables are therefore a focal point, 
especially as both the ICD-10 (WHO 1993) and the DSM-IV (APA-1994) fail to list any such 
specific criteria for AS children, apart from insisting that there is a normal onset of language. In 
addition, the term in the ICD-10 (WHO 1993) which states that “single words should have 
developed by two years of age or earlier and that communicative phrases be used by three years of 
age or earlier” can also be questioned. In a way, the term ‘should’ leaves the door open for any 
speculations about language development and makes it possible to set a diagnosis of AS, even if 
there is some delay in language development. The same argument is also valid for the DSM-IV 
(APA 1994), as it is not stated what is meant by cognitive language delay. 
Motor ability
The ICD-10 (WHO 1993) states that “however, motor milestones may be somewhat delayed and 
motor clumsiness is usual (although not a necessary feature)”. Neither the ICD-10 (WHO 1993) 
nor the DSM-IV (APA 1994) criteria specifically include motor difficulties, even if they are often 
described in clinical work. Asperger (1944) himself noted that his child cases often had delayed 
motor skills, as well as problems of motor co-ordination. In contrast, in younger children with 
autism, motor ability may be an area of relative strength. In older individuals, the difference is less 
notable, making this feature less discriminating between autism and AS (Klin and Volkmar 1997, 
Volkmar and Klin 2000). Among many of the behaviours he referred to, Hans Asperger (1944) 
also noted a tendency towards uncoordinated, "clumsy" gross motor movements (Asperger 1944).  
In a community-based study, Green and co-workers (2002) compared motor impairment in 11 
children with AS (6.6-10.7 years; mean 110.5; SD 18.2) with a matched group of nine children 
(6.8-9.8 years; mean 103.9; SD 13.7) with Specific Developmental Disorder of Motor Function 
(SDD-MF). They used The Movement Assessment Battery for Children (provides a standardised 
test of motor impairment and a Gesture Test, which is used to assess the child's ability to mime the 
use of familiar tools and to imitate meaningless sequences of movements). The ADI-R was used to 
identify features of AS in the first group and to exclude them in the latter one. All children with AS 
fulfilled the criteria for motor impairment and the overall performance pattern of the AS children 
did not differ from that of the other group. This and other studies support the concept of a high 
prevalence of clumsiness in AS (Green et al. 2002).  
Taken together, the validity of AS, HFA and autism as distinctive diagnostic concepts remains 
inadequately addressed. Instead of focusing on the question of AS vis-à-vis autism, studies of other 
clinical features should be performed and added to the tools now used in the diagnostic work. More 
research is needed on communication development in AS to determine whether future revisions of 
the DSM-IV and ICD-10 need to include particular kinds of communication impairment as AS 
criteria. The alternative would be to delete language delay as an exclusion criterion.  
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Features not included in the DSM-IV or ICD-10 
There is also direct and indirect evidence that a number of clinical features, i.e. prosopagnosia (face 
blindness), sleeping difficulties, unusual sensory responses, which are not used as official criteria 
in the DSM-IV or ICD-10 for AS, occur fairly frequently in this syndrome. Prosopagnosia has been 
reported in a number of individuals with AS in case reports (Kracke 1994, Njiokiktjien et al. 2001, 
Duchaine et al. 2003, Pietz et al. 2003), indicating that the deficient observation of facial emotional 
expressions may be an important pathogenic symptom  of autistic behaviour (Kracke 1994, 
Njiokiktjien et al. 2001). 
Abnormal sleep patterns in AS have been reported by Paavonen and co-workers (2003) and Tani 
and co-workers (2003), in children and adults respectively. In the children with AS, melatonin 
improved the sleep patterns in all individuals and half of them displayed excellent responses 
(Paavonen et al. 2003). In a hospital-based series by Tani and co-workers (2003) comprising 20 
adults with AS, the sleep questionnaire revealed insomnia in 90%, while the sleep diary revealed it 
in 75%.
Unusual sensory responses (e.g. hypo- and hyper-responses; preoccupation with the sensory 
features of objects, perceptual distortions; paradoxical responses to sensory stimuli; i.e. touch, pain, 
heat, cold, sound and light) have been reported in 42% to 88% of children with autism (Kientz and 
Dunn 1997, Le Couteur et al. 1989). There is only one study dealing with sensory features in AS. 
The study by Jansson-Verkasalo and co-workers (2002) indicated that auditory sensory processing 
was deficient in children with AS. Studying auditory event-related potentials in ten children (4 
females, 6 males) with AS (age span 7-12; mean 9.1; standard error of the mean 0.46) and 11 
controls (age range 7-12; mean 9.6; standard error of the mean 0.46) using the mismatch-negativity 
(MMN) technique, they demonstrated abnormalities in transient sound-feature encoding and in 
sound discrimination (Jansson-Verkasalo et al. 2002). 
Does Asperger’s syndrome truly exist?  
The controversy still prevails as to whether AS deserves diagnostic status at all. There are some 
studies which have used the DSM-IV criteria to evaluate AS but have reached the conclusion that it 
is virtually unworkable to make a DSM-IV diagnosis of AS (Eisenmajer et al. 1996, Miller and 
Ozonoff 1997, Mayes et al. 2001). Miller and Ozonoff (1997) examined the four cases Asperger 
originally presented in his paper, using the DSM-IV criteria to determine whether a diagnosis of 
autism or AS is most appropriate. They found that all four cases met the DSM-IV criteria for 
autism but not for AS. Miller and co-workers (1997) concluded that the syndrome Asperger 
originally described might not be captured by the present DSM-IV diagnostic criteria.    
In a retrospective hospital-based study by Mayes and co-workers (2001), 157 children previously 
evaluated at a child psychiatric clinic at a university hospital, with the diagnosis of autism or AS, 
range 19 months to 14.4 years (mean 5.1 years), were analysed (analysis of questionnaires and 
behaviour rating scales completed by the child’s parents and teachers, intelligence test, clinical 
observation of the child, parental interview and review of historical data) to determine whether the 
DSM-IV criteria were applied for AS. The result revealed that 100% of the group met the criteria 
for autism, but none met the criteria for AS. The result should be viewed as a consequence of the 
DSM-IV criteria which state that persons who fulfil the criteria for autism and AS should be 
diagnosed with autism, also including those with normal intelligence and an absence of early 
speech delay (Mayes et al. 2001). Since the DSM-IV specifies that persons who fulfil the criteria 
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for autism and AS should be diagnosed with autism, the DSM-IV criteria for AS are not widely 
applicable (Szatmari 2000).  
5.3.2 FORMER DIAGNOSTIC CRITERIA 
Before the official diagnostic criteria included in the ICD-10 and DSM-IV were introduced, 
Gillberg and Gillberg (1989) (Table 4) and Szatmari and co-workers (1989) (Table 5) presented 
sets of diagnostic criteria independently of each other. In Gillberg's classification, there are six 
domains comprising social impairments, narrow interest, repetitive routines, speech and language 
peculiarities, non-verbal communication problems and motor clumsiness (Gillberg and Gillberg 
1989, Ehlers and Gillberg 1993). Szatmari and co-workers (1989) defined four domains, which 
cover solitariness, impaired social interaction, impaired non-verbal communication and odd 
speech.
Table 4. Diagnostic criteria for Asperger's disorder (Gillberg and Gillberg 1989) 
A. Severe impairment in reciprocal social interaction as manifested by at least two of the following four: 
   1. Inability to interact with peers 
   2. Lack of desire to interact with peers 
   3. Lack of appreciation of social cues 
   4. Socially and emotionally inappropriate behaviour 
B. All-absorbing narrow interest, as manifested by at least one of the following three: 
   1. Exclusion of other activities 
   2. Repetitive adherence 
   3. More rote than meaning  
C. Speech and language problems, as manifested by at least three of the following five: 
    1. Delayed development of language 
    2. Superficially perfect expressive language 
    3. Formal, pedantic language 
    4. Odd prosody, peculiar voice characteristics 
    5. Impairment of comprehension, including misinterpretations of literal/implied meanings 
D. Non-verbal communication problems, as manifested by at least one of the following five: 
    1. Limited use of gestures 
    2. Clumsy/gauche body language 
    3. Limited facial expression 
    4. Inappropriate expression 
    5. Peculiar, stiff gaze 
E. Motor clumsiness, as documented by poor performance on neurodevelopmental examination. 
All six criteria must be met for confirmation of diagnosis 
According to the literature, comparing the official present diagnostic criteria with the criteria used 
before, the ICD-10 and DSM-IV correspond least with Asperger’s own description, whereas the 
criteria presented by Gillberg and Gillberg (1989) appear to be closest but not identical to 
Asperger’s own descriptions and case histories (Leekam et al. 2000). In spite of this, the ICD-10 
and DSM-IV are the currently-used official criteria, which may exclude those subjects who would 
have met the diagnosis for AS according to Asperger himself. 
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There are similarities for all of the diagnostic sets of criteria, as well as differences. The ICD-10 
(WHO 1993) and DSM-IV (APA 1994) require normal cognitive development and no delay in 
language development, but this is the opposite of the set of criteria presented by Gillberg and 
Gillberg (1989), where delayed language development is accepted. The diagnostic sets of criteria 
produced by Szatmari and co-workers (1989) and Gillberg and Gillberg (1989) do not mention 
cognitive functions, or early language development. This implies that a person with cognitive 
retardation would comply with AS diagnostic criteria. Unlike the criteria of Gillberg and Gillberg 
(1989) and Szatmari (1989), those in the ICD-10 (WHO 1993) and DSM-IV (APA 1994) do not 
include abnormalities in the way language is used or impairments of non-verbal communication. 
Asperger (1944) himself emphasised both these features, when he described the large vocabularies 
of the four children but also noted their odd intonation, their inappropriate use of speech and, in 
some cases, their reversal of pronouns.
Table 5. Diagnostic criteria for Asperger's disorder (Szatmari et al. 1989) 
A. Solitary, as manifested by at least two of the following four: 
    1. No close friends 
    2. Avoids others 
    3. No interest in making friends 
    4. A loner 
B. Impaired social interaction, as manifested by at least one of the following five: 
    1. Approaches others only to have own needs met 
    2. A clumsy social approach 
    3. One-sided responses to peers 
    4. Difficulty sensing feelings of others 
    5. Detached from feelings of others 
C. Impaired non-verbal communication, as manifested by at least one of the following seven: 
    1. Limited facial expression 
    2. Unable to read emotion from facial expressions of child 
    3. Unable to give messages with eyes 
    4. Does not look at others 
    5. Does not use hands to express oneself 
    6. Gestures are large and clumsy 
    7. Comes too close to others 
D. Odd speech, as manifested by at least two of the following six: 
    1. Abnormalities in inflection 
    2. Talks too much 
    3. Talks too little 
    4. Lack of cohesion to conversation 
    5. Idiosyncratic use of words 
    6. Repetitive patterns of speech 
Motor clumsiness is included in the ICD-10 (WHO 1993), which states that motor clumsiness is 
common (although not a compulsory feature). Asperger himself (1944) included motor clumsiness 
in his description of AS. Contrary to this, the set of criteria developed by Gillberg and Gillberg 
(1989) require motor clumsiness for a diagnosis of AS. This means that those who meet the criteria 
for AS in the Gillberg criteria do not necessarily do so in the ICD-10. In a hospital-based study by 
Leekam and co-workers (2000), the ICD-10 and Gillberg’s criteria for AS were compared using a 
study algorithm designed for the Diagnostic Interview for Social and Communication Disorders 
(DISCO). The study group consisted of 200 children and adults (age 32 months to 38 years; mean 
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12.7; SD 8.1), all of whom met the ICD-10 criteria for childhood autism. Only 1% (3 children) of 
them met the ICD-10 criteria for AS, but, in contrast, 45% (91 children) met the diagnosis for AS 
when defined by the criteria developed by Gillberg and Gillberg (1989). The discrepancy was due 
to the requirement included in the ICD-10 of having normal cognitive development, language 
curiosity and self-help skills (Leekam et al. 2000).  
5.3.3 SCREENING INSTRUMENTS 
The ICD-10 (WHO 1993) and DSM-IV (APA 1994) are the official diagnostic criteria that are 
used for Asperger syndrome, but a wide range of screening instruments for autism spectrum 
disorders has been devised in recent decades. The ASSQ (Autism Spectrum Screening 
Questionnaire) (Ehlers and Gillberg 1993, Ehlers et al. 1999) is widely used and is considered to be 
a reliable and valid parent and teacher screening instrument for high-functioning autism spectrum 
disorders in a clinical setting (Ehlers et al. 1999). It identifies the children with autistic-like 
conditions who are on the borderline of autism, with an average range of intelligence referred to as 
HFA and AS (Ehlers et al. 1999). There is a danger and also a temptation to use this tool as a 
diagnostic tool, which is not the correct way to confirm a diagnosis, as the ASSQ has not been 
validated. 
The ASDI (Asperger Syndrome Diagnostic Interview) is an interview directed towards youngsters 
and adults with AS (Gillberg et al. 2001). The inter-rater reliability and test-retest stability are 
excellent, with kappa coefficients exceeding 0.90 in both instances, and the validity also appears to 
be relatively good (Gillberg et al. 2001). In this particular study, the instrument was not validated 
with respect to the distinction between AS and HFA (Gillberg et al. 2001). The ASDASQ (Autism 
Spectrum Disorder in Adults Screening Questionnaire) is used in adult psychiatric patients for 
screening purposes to determine whether they have undiagnosed autism spectrum disorders 
(Nylander and Gillberg 2001).  
For general clinicians, it is important to remember the possibility of autism spectrum disorders, 
especially when working with persons with neuropsychiatric disabilities. The screening 
instruments are useful before starting the clinical diagnostic evaluation (Nylander and Gillberg 
2001).
5.3.4 OTHER DIAGNOSTIC TOOLS 
There is a lack of AS-specific diagnostic instruments, but there are two useful ones for the 
diagnostic process involving persons with AS. They are the Autism Diagnostic Interview–Revised  
(ADI-R) (Lord et al. 1994) and the Autism Diagnostic Observation Schedule (ADOS) (Lord et al. 
1989). The ADI-R is an investigator-based interview containing structured coding for each 
behavioural item, focusing on reciprocal social interactions, communication and stereotyped 
patterns of behaviour and interests of autism and related conditions. It consists of six sections 
dealing with background orientation, developmental history and previous and current behaviour. 
The ADI-R is relevant for the diagnosis of individuals with high-functioning disabilities, as the 
symptomatology is graded in terms of severity, making the instrument more sensitive to AS (Klin 
et al. 2000). Scores on the ADI-R can be used to derive an algorithm for the ICD-10 (WHO 1993) 
and DSM-IV (APA 1994) criteria for autism spectrum disorders (Volkmar and Lord 1998) and this 
can be partly used when formulating a diagnosis. The use of the ADI-R requires training before it 
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can be used reliably, but it provides a valuable framework for collecting information and is helpful 
in clinical work.  
Although the direct observation of the child or adolescent is an essential part of any clinical 
assessment, it must be recognised that this observation usually takes place in an unfamiliar setting 
and does not necessarily represent the most reliable means of reaching a firm diagnosis. In AS, this 
observation of the child may not be reliable enough or may provide only limited information, but 
there is a more structured observation assessment, the ADOS. It is a structured and semi-structured 
standardised assessment of communication, social interaction and play or the imaginative use of 
materials by individuals who have been referred because of possible autism spectrum disorders 
(Lord et al. 1994). It consists of a series of structured tasks that are designed to assess the child’s 
social and communicative functioning, including constructional and turn-taking activities, 
imitation, the ability to tell a story, imaginative toy play, gesture and conversational skills. The 
ADOS provides a range of social communication adapted to the developmental level of the 
individual who is being tested (Lord et al. 1994). The ADOS includes four modules, defined in 
terms of the child’s expressive language capacities. Modules 3 and 4 are appropriate for children 
and adolescents with fluent speech and in most cases modules 3 and 4 would therefore be 
applicable in AS (Klin et al. 2000). 
The ADI-R and ADOS complement each other. Both instruments provide a measure of the severity 
of autistic symptomatology. They were originally developed as investigator-based interviews to be 
used in research studies of autism.  
5.4 DIFFERENTIAL DIAGNOSTICS AND CO-MORBIDITY
5.4.1 HIGH FUNCTIONING AUTISM 
In children and adolescents diagnosed with AS, there are often other symptoms and disorders 
which are not accounted for by AS. There are a number of overlapping/co-morbid behavioural 
syndromes and a number of overlapping/co-morbid symptoms that do not by themselves constitute 
the status of “disorder diagnosis”. What raises most confusion and debate is the distinction between 
high functioning autism (HFA) and AS – are they separate clinical entities or not? Very few studies 
have addressed this question (Gillberg 1989, Gillberg 1998, Kugler 1998, Klin et al. 2000).  
There are currently no explicit diagnostic guidelines for the diagnosis of HFA. The most 
commonly used practice is to set a diagnosis of AS whenever the DSM-IV (APA 1994) and/or 
ICD-10 (WHO 1993) diagnostic criteria for autistic disorder are fulfilled and the total IQ is above 
65-70 (Gillberg 1998).  
According to Klin and co-workers (2000), AS differs from HFA by later onset and a more 
favourable outcome. In addition, social and communication deficits are less severe, motor 
mannerisms are usually missing, whereas circumscribed interests are more conspicuous and motor 
clumsiness is apparently more frequently seen in AS (Klin et al. 2000). There are also some 
indications that a family history of similar problems is more frequently seen in AS than in HFA 
(Gillberg 1989, Gillberg 1998, Klin et al. 2000). The most controversial issues in the diagnosis of 
AS versus HFA relate to 1) language disability, 2) cognitive functioning (Gillberg 1998, Kugler 
1998), 3) special interests, 4) social interaction (Kugler 1998) and 5) motor skills, (Gillberg 1998, 
Kugler 1998). 
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Language
When differentiating between HFA and AS, the most difficult diagnostic issue perhaps relates to 
early language development. As already mentioned, in his paper (1944) Asperger himself included 
comments on adult-like speech and an unusually mature and adult manner of self-expression. 
Gillberg (1991) stressed that the AS children Gillberg himself described ‘all had good or very good 
expressive language skills and they all had developed a near-normal level of speech by the age of 
five’. In the paper by Kugler (1998) comparing different studies of AS vs. HFA, the conclusion  
was that more deviation in language and communication is apparent in HFA, both in terms of 
reported early behaviours, such as echolalia, repetitive speech, and in terms of deficits in 
articulation, vocabulary and verbal output assessed in later life. More specifically, marked 
verbosity, with lengthy speech or incessant monologues, has been suggested to characterise AS and 
distinguish it from HFA (Klin 1995). According to Ghaziuddin and Gernstein (1996), a pedantic 
speaking style differentiates AS from HFA.  
Cognitive function
The criteria included in the ICD-10 (WHO 1993) and DSM-IV (DSM-IV) are not compatible with 
general cognitive retardation (WHO-1993, DSM-IV 1994). Klin and co-workers (1995) and 
Gillberg (1998) and Kugler (1998) concluded that the combination of a higher VIQ (verbal 
intelligence quotient) and a lower PIQ (performance intelligence quotient) was a general finding in 
AS but not in HFA. This implies that, despite similar general levels of functioning, patterns of 
verbal and non-verbal abilities are significantly different in AS and HFA. According to Gillberg 
(1998), the overall IQ tends to be higher in AS than in HFA, even when the requirement for 
inclusion in the studies of AS vs. HFA has been an IQ of 70 and above.  
The neuropsychological domain that has been hypothesised to distinguish AS from HFA is the 
Theory of Mind (ToM). ToM describes a person’s ability to think about information about his or 
her and others’ mental states (Happe et al. 1994, Baron-Cohen and Wheelwright 1999, Ozonoff 
and Griffith 2000, Ozonoff et al. 2000, Perner and Lang 2000). In several studies reviewed by 
Kugler (1998) and Ozonoff and Griffith (2000), the conclusion is that first order theory of mind 
(ToM), which is a strength in AS, was one of the weakest skills in HFA. According to Ozonoff and 
Griffith (2000), the performance on ToM tasks may be highly dependent on other cognitive 
abilities, such as verbal skills and executive function (defined for the many skills required to 
prepare for and execute complex behaviour, including planning, inhibition, mental flexibility and 
mental representation of tasks and goals) (Pennington BF and Ozonoff 1996, Ozonoff and Griffith 
2000). The differences in ToM may be due to the better verbal abilities of AS subjects and, 
conversely, ToM skills may rely on good linguistic abilities. A good performance by people with 
AS in the ToM tests may also be regarded not as proof of ToM ability but rather as evidence of a 
strategy the AS individuals have developed or learned or as a reflection of  the theory (Ozonoff and 
Griffith 2000). 
Specific skills
In terms of specific skills, children with AS have been reported to have better verbal reasoning 
abilities than children with HFA (Kugler 1998, Ozonoff and Griffith 2000) and to perform better in 
verbal memory and auditory perception tasks (Kugler 1998). However, children with AS display 
deficits in visual-motor integration, visual-spatial perception, visual memory, non-verbal concept 
formation and emotional perception, which are stronger in HFA. Poor social and emotional 
competence and problems of verbal concept formation have been shown to be similar in both 
groups (Klin et al. 1995, Kugler 1998). According to Kugler (1998) and his analysis of the 
different studies, abnormal preoccupations and interests have been noted to be more common in 
AS than in HFA. All–absorbing, circumscribed special interests, with a huge amassing of factual 
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information in AS, have been contrasted with the manipulative, visual-spatial and musical skills or 
savant talents more commonly described in HFA (Klin 1995). Gillberg (1991) suggested that the 
imposition of the preoccupations on other people is characteristic of AS. Asperger (1944) himself 
again described the growing development of isolated skills. There is emerging support to suggest 
that these skills are typical of AS and should be given due consideration when the necessary 
requirements for the diagnosis are specified (Kugler 1998). 
Motor functions
According to Gillberg (1998), a diagnosis of AS would entail more motor control problems than a 
diagnosis of HFA. Klin and co-workers (1995) reported more deficits in both fine- and gross-motor 
skills in AS than in HFA. There are five studies which directly compare  motor development and 
function in individuals with AS with those in HFA. Ozonoff and Griffith (2000) have summarised 
them all, demonstrating in their résumé that two of the studies showed selective deficits in the AS 
group, two found no group differences and one reported mixed results. A study that was not 
included in the summary by Ozonoff and Griffith (2000) is the study by Eisenmajer and co-
workers (1996). The conclusion in this investigation was that the only significant difference 
between the groups with AS and controls was that, in motor development, the HFA group walked 
later than the AS group (Eisenmajer et al. 1996). 
From a clinical point of view, one of the most problematic overlaps in differential diagnosis is the 
interface of HFA. Although comparative studies have been conducted on AS and HFA, the 
information that is essential when it comes to differentiating or whether to differentiate at all is not 
yet available (Gillberg 1989, Gillberg 1991, Szatmari et al. 1995, Eisenmajer et al. 1996, Gillberg 
1998; Kugler 1998, Klin 1994, Klin et al. 1995, Baron-Cohen 2000, Klin et al. 2000, Ozonoff and 
Griffith 2000). It is critical for both research and intervention to determine whether or not AS and 
HFA are different entities. If they are different conditions, it would be inappropriate to group them 
together for research purposes. On the other hand, if AS and HFA share the same fundamental 
symptomatology, differing only in degree or severity, then retaining the use of different labels for 
the same disability would be confusing.  
Other differential diagnoses and/or co-morbidity 
The issue of co-morbidity is slightly contentious in that it is not always obvious what is inferred by 
the term. Co-morbidity with a given condition could be coincidental, causally directly related, one 
condition leading to the other, or causally indirectly related, another underlying condition leading 
both to the core problem and to the co-morbid disorder/disorders (Gillberg and Billstedt 2000). 
Hans Asperger (1944) described co-morbidity in his paper when following 200 cases of AS of 
which only one developed schizophrenia. In her series, Wing (1981) discovered that, of the 18 
individuals aged 16 and over at the time of her evaluation, four had an affective illness, four had 
become increasingly odd and withdrawn, probably with underlying depression, and one had 
psychosis with delusions and hallucinations that could not be classified, one had had one episode of 
catatonic stupor, one displayed bizarre behaviour and had an unconfirmed diagnosis of 
schizophrenia and two displayed bizarre behaviour, but had no diagnosable psychiatric illness.  
The focal point in co-morbidity or differential diagnostics is schizophrenia, schizoid personality, 
schizotypal personality disorder, attention deficit hyperactivity disorder (ADHD), Tourette 
syndrome, HFA (already referred to), anorexia nervosa, mutism and obsessive-compulsive disorder 
(OCD).  
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5.4.2 SCHIZOPHRENIA, SCHIZOID PERSONALITY, SCHIZOTYPAL PERSONALITY  
Schizophrenia 
In 1909, Kraepelin described a disorder called dementia praecox (early deterioration of the 
intellect), which was subsequently given the name schizophrenia (schiz = split, phrenia = mind) 
(Bleuler 1911). Schizophrenia is regarded as a group of disorders (Bleuler 1911) with multiple 
symptoms and signs, which involve the impairment of cognitive and emotional functions such as 
perception (hallucinations), motivation, thought, emotion and behaviour. Schizophrenia is 
characterised by psychotic episodes, which can be accompanied by hallucinations, disordered 
memory and confusion. The symptoms of the psychotic episodes are referred to as positive 
symptoms (hallucinations, delusions, bizarre behaviour, paranoid ideation) (Konstantareas and 
Hewitt 2001, Carmine 2003), as they reflect the presence of distinctly abnormal behaviour. The 
symptoms of the non-psychotic periods are referred to as negative symptoms (deficiencies in 
emotional responsiveness, spontaneous speech and volition, flattening of affect, poverty of speech, 
lack of volition and drive, loss of feeling, social withdrawal and decreased spontaneous movement) 
(Konstantareas and Hewitt 2001, Carmine 2003), because they reflect the absence of certain 
normal social and interpersonal functions (Carmine 2003).  
Table 6. Diagnostic criteria for schizophrenia (ICD-10) (WHO 1992)  
A. Characteristic symptoms: Two or more of the following, each present for a significant portion of time during 
a one-month period:  
1. Delusions  
2. Hallucinations  
3. Disorganised speech (e.g. frequent derailment or incoherence)  
4. Grossly disorganised or catatonic behaviour  
5. Negative symptoms (e.g. affective flattening, alogia, or avolition) 
Only one Criterion A symptom is required if delusions are bizarre or hallucinations consist of a voice keeping up a 
running commentary on the person's behaviour or thoughts, or two or more voices conversing with each other. 
B. Social/occupational dysfunction: since the onset of the disturbance, one or more major areas of functioning, such 
as work, interpersonal relations, or self-care, are markedly below the level previously achieved.
C. Duration: continuous signs of the disturbance persist for at least six months. This six-month period must include at 
least one month of symptoms (or less if successfully treated) that meet Criterion A. 
D. Exclusion of schizoaffective disorder and mood disorder with psychotic features 
E. Substance/general medical condition exclusion: the disturbance is not due to the direct physiological effects of a 
substance (e.g., a drug of abuse, a medication) or a general medical condition.
F. Relationship to a pervasive developmental disorder: if there is a history of autistic disorder or another pervasive 
development disorder, the diagnosis of schizophrenia is made only if prominent delusions or hallucinations are also 
present for at least a month (or less if successfully treated). 
The diagnosis of schizophrenia (Table 6) is often based on negative symptoms and the absence of a 
developmental history (Tantam 2000). Diagnostic difficulty may arise when there is no reliable 
developmental history and when a person with apparent AS reports abnormal ideas and 
experiences. Another situation in which the possibility of a schizophrenia diagnosis is raised is 
when psychosis occurs in a person with AS. There is no evidence in the literature that 
 26 
schizophrenia is more common in people with AS than in the general population (Tantam 2000). 
Volkmar and Cohen (1991) have concluded that the frequency of schizophrenia in individuals with 
autism is around 0.6%, which is roughly comparable to that in the general population, and as they 
state “it does not appear that the two conditions are more commonly observed together than would 
be expected on a chance basis" (Volkmar and Cohen 1991). The rates of schizophrenia appear to be 
relatively low in studies of individuals with AS. In a study of individuals with AS, Wing (1981) 
describes one with an unconfirmed diagnosis of schizophrenia. Tantam (1991) diagnosed three 
cases of schizophrenia in 83 individuals with AS but noted that the figure is likely to be higher than 
in an unselected population, because the individuals in the study were all psychiatric referrals.  
Konstantareas and Hewitt (2001) studied 14 males with autistic disorder (AD) (age range 17–33; 
mean 25.3, SD 4.48) and 14 with schizophrenia (age range 23–39; mean 29.5; SD 5.14). They 
collected data to examine symptom overlap. The Structured Clinical Interview (SCID), the 
schedule for positive symptoms (SAPS) and the schedule for negative symptoms (SANS) of 
schizophrenia, the Childhood Autism Rating Scale (CARS) and the DSM-III-R were administered. 
On the SCID, none of the men with paranoid schizophrenia met the criteria for autism, while seven 
of those with autism met the criteria for schizophrenia, the disorganised type showing negative 
symptoms, whereas none met the criteria for the paranoid subtype. In addition, five individuals 
with autism reported positive symptoms on the SAPS, while six reported negative symptoms on the 
SANS. Although the individuals with schizophrenia were significantly less likely to display most 
of the characteristics of autism spectrum disorders, they were not different from people with autism 
spectrum disorders in three areas, namely, consistency of intellectual response, lack of interest in 
imitation and extremes in activity level. These can be seen as being comparable to the negative 
symptoms of schizophrenia. Some of the most visible symptoms of autism spectrum disorders were 
also those that best differentiated the two groups, such as stereotypical and inappropriate 
behaviours, resistance to change, sensory preoccupations and difficulty in non-verbal 
communication. It appears that these latter symptoms are therefore quite specific to autism 
spectrum disorders and are not shared by at least the subgroup which met the criteria for the 
paranoid subtype of schizophrenia. The symptoms that differentiated the two groups are visible to 
others and are in fact a source of distress to parents (Kontantareas and Hewitt 2001).  
Schizoid personality 
Schizoid personality disorder is a source of considerable diagnostic confusion. The disorder 
described in the ICD-10 (WHO 1992) (Table 7) (DSM-IV) (APA 1994) (Table 8) is defined by 
coldness, indifference to others’ opinions and insensitivity. It is also a diagnosis that is often 
associated with eccentricity (Tantam 2000).  
Wolff used the concept of schizoid personality disorder when she wrote about children with 
isolation and emotional detachment, unusual communicative style and rigidity of thought and 
behaviour (Tantam 2000, Volkmar and Klin 2000, Wolff 2000). The study Wolff described was a 
retrospective case note analysis of 32 matched pairs of schizoid and control boys who had been 
followed up (from a total cohort of 109 schizoid boys and their controls) for 20 years and of 33 
matched pairs of girls, of whom 17 were followed up. The mean age of the schizoid children at 
referral was 9.8 years for boys and 10 years for girls and their mean IQ was 109 and 103 
respectively (Wolff 2000). As a group, the children Wolff described were much less impaired in 
both childhood and adult life than individuals with AS and they did not fully meet the diagnostic 
criteria for AS in the ICD-10 (WHO 1992) or DSM-IV (APA 1994). The same group was also 
followed up to determine whether there was a link between schizoid personality and schizophrenia. 
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The number was small but suggested that the subsequent risk of schizophrenia was about 10 times 
greater than in the general population (Wolff 2000).  
Table 7. Diagnostic criteria for Schizoid Personality Disorder (ICD-10) (WHO 1992)  
Personality disorder characterized by at least three of the following:  
1. Few, if any, activities provide pleasure 
2. Emotional coldness, detachment or flattened affectivity 
3. Limited capacity to express either warm, tender feelings or anger towards others 
4. Apparent indifference to either praise or criticism  
5. Little interest in having sexual experiences with another person (taking account of age)  
6. Almost invariable preference for solitary activities 
7. Excessive preoccupation with fantasy and introspection 
8. Lack of close friends or confiding relationships (or having only one) and of desire for such relationships 
9. Marked insensitivity to prevailing social norms and conventions  
Excludes:
* Asperger syndrome  
* delusional disorder  
* schizoid disorder of childhood  
* schizophrenia  
* schizotypal disorder  
Table 8. Diagnostic criteria for Schizotypal Personality Disorder (DSM-IV) (APA 1994) 
A pervasive pattern of detachment from social relationships and a restricted range of expression of emotions in 
interpersonal settings, beginning by early adulthood and present in a variety of contexts, as indicated by four 
(or more) of the following:  
1. Neither desires nor enjoys close relationships, including being part of a family  
2. Almost always chooses solitary activities  
3. Has little, if any, interest in having sexual experiences with another person  
4. Takes pleasure in few, if any, activities  
5. Lacks close friends or confidants other than first-degree relatives  
6. Appears indifferent to the praise or criticism of others  
7. Shows emotional coldness, detachment, or flattened affectivity  
B. Does not occur exclusively during the course of Schizophrenia, a Mood Disorder With Psychotic Features, 
another Psychotic Disorder, or a Pervasive Developmental Disorder and is not due to the direct physiological 
effects of a general medical condition.  
Note: If criteria are met prior to the onset of Schizophrenia, add "Premorbid," e.g. "Schizoid Personality Disorder 
(Premorbid)." 
Wolff (2000) herself pointed out that the children she described could be classified either as having 
schizoid/schizotypal personality disorder or as having Asperger’s autistic psychopathy according to 
the original description of this syndrome (Asperger 1944). (One has to be aware of the fact that, in 
German, “psychopathy” means personality disorder.) Wolff also remarked that the current 
diagnostic category of AS would be appropriate only if the criteria in both the DSM-IV (APA 
1994) and ICD-10 (WHO 1992) were modified. The modifications necessary to include schizoid 
children would be (1) to omit the exclusion criterion of clinically significant delays in speech and 
language, (2) to omit the exclusion criterion for schizoid and schizotypal disorders, (3) to specify 
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the less social impairments and the more sophisticated all-absorbing interests in comparing with 
autism and (4) to include a criterion for unusual fantasy. To sum up , Wolff (2000) pointed out that 
the concepts of PDD of schizoid/schizotypal may not be as discrepant as current classifications 
suggest. 
Schizotypal personality 
Schizotypal personality disorder (Table 9, Table 10) occurs in families with schizophrenia. The 
category of schizotypal personality disorder was devised for personality characteristics found to 
excess in the biological relatives of schizophrenia patients and previously subsumed under the 
more general category of schizoid personality disorder (Wolff 2000). 
Table 9. Diagnostic criteria for schizotypal disorder (ICD-10) (WHO 1992) 
A disorder characterised by eccentric behaviour and anomalies of thinking and affect, which resemble those 
seen in schizophrenia, although no definite and characteristic schizophrenic anomalies have occurred at any 
stage. There is no dominant or typical disturbance, but any of the following may be present:  
1. Inappropriate or constricted affect (the individual appears cold and aloof) 
2. Behaviour or appearance that is odd, eccentric, or peculiar  
3. Poor rapport with others and a tendency to social withdrawal 
4. Odd beliefs or magical thinking, influencing behaviour and inconsistent with subcultural norms;  
5. Suspiciousness or paranoid ideas  
6. Obsessive ruminations without inner resistance, often with dysmorphophobic, sexual or aggressive contents 
7. Unusual perceptual experiences including somatosensory (bodily) or other illusions, depersonalization or  
   derealization  
8. Vague, circumstantial, metaphorical, overelaborate, or stereotyped thinking, manifested by odd speech or in other   
    ways, without gross incoherence  
9.Occasional transient quasi-psychotic episodes with intense illusions, auditory or other hallucinations, and delusion-       
   like ideas, usually occurring without external provocation 
The disorder runs a chronic course with fluctuations of intensity. Occasionally it evolves into overt schizophrenia. 
There is no definite onset and its evolution and course are usually those of a personality disorder. It is more common in 
individuals related to schizophrenics and is believed to be part of the genetic "spectrum" of schizophrenia 
Diagnostic guidelines 
This diagnostic rubric is not recommended for general use because it is not clearly demarcated either from 
simple schizophrenia or from schizoid or paranoid personality disorders. If the term is used, three or four of the 
typical features listed above should have been present, continuously or episodically, for at least two years. The 
individual must never have met the criteria for schizophrenia itself. A history of schizophrenia in a first-degree 
relative gives additional weight to the diagnosis but is not a prerequisite.
Includes:  
* borderline schizophrenia  
* latent schizophrenia  
* latent schizophrenic reaction  
* prepsychotic schizophrenia  
* prodromal schizophrenia  
* pseudoneurotic schizophrenia  
* pseudopsychopathic schizophrenia  
* schizotypal personality disorder  
Excludes:  
* Asperger's syndrome  
* schizoid personality disorder  
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Table 10. Diagnostic criteria for Schizoid Personality Disorder (DSM-IV)(APA 1994)
A pervasive pattern of social and interpersonal deficits marked by acute discomfort with, and reduced capacity 
for, close relationships, as well as by cognitive or perceptual distortions and eccentricities of behaviour, 
beginning by early adulthood and present in a variety of contexts, as indicated by five (or more) of the 
following:  
1. Ideas of reference (excluding delusions of reference)  
2. Odd beliefs or magical thinking that influences behaviour and is inconsistent with subcultural norms (e.g.,  
    superstitiousness, belief in clairvoyance, telepathy, or "sixth sense"; in children and adolescents, bizarre fantasies or  
    preoccupations)  
3. Unusual perceptual experiences, including bodily illusions  
4. Odd thinking and speech (e.g. vague, circumstantial, metaphorical, overelaborate, or stereotyped)  
5. Suspiciousness or paranoid ideation  
6. Inappropriate or constricted affect  
7. Behaviour or appearance that is odd, eccentric, or peculiar  
8. Lack of close friends or confidants other than first-degree relatives  
9 Excessive social anxiety that does not diminish with familiarity and tends to be associated with paranoid fears rather  
   than negative judgments about self  
Does not occur exclusively during the course of Schizophrenia, a Mood Disorder With Psychotic Features, 
another Psychotic Disorder, or a Pervasive Developmental Disorder.  
Note: If criteria are met prior to the onset of Schizophrenia, add "Premorbid," e.g. "Schizotypal Personality Disorder 
(Premorbid)."
Nagy and Szatmari (1986) described 20 children as schizotypal and recognised similarities to the 
cases described by Asperger (1944). Their specific features were social isolation, social anxiety, 
magical thinking, bizarre preoccupations and odd speech. The authors suggested that the disorder 
might be a mild form of Kanner’s autism or a variant of adult schizophrenia, or neither (Nagy and 
Szatmari 1986). Whereas the DSM-IV (APA 1994) emphasises such features as magical thinking 
and illusions, the specific signs and symptoms of schizotypal personality disorder that best 
distinguish the family members of schizophrenics from normal family members (control group) are 
the same ones that define AS: odd speech, social dysfunction, avoidant symptoms and “negative 
schizotypy”, which include poor rapport, aloofness, guardedness and odd behaviour (Folstein and 
Santangelo 2000, Pearlson 2000).  
5.4.3 ATTENTION DEFICIT HYPERACTIVITY DISORDER 
Attention deficit hyperactivity disorder (ADHD) is characterised by impaired attention, excessive 
motor activity and impulsiveness, all of which hamper social interaction (Ernst et al. 1999). Very 
few studies have systematically addressed the evidence linking autism and ADHD and only one 
study has focused on the co-morbidity of AS and ADHD. The probable reason for this is the 
restriction in the manual (e.g. ICD-10, DSM-IV) stating that autism and ADHD should not be 
diagnosed conjointly in any individual person (Gillberg and Billstedt 2000, Schatz 2002). In 
Ghaziuddin and co-workers' (1998) study of 35 persons (29 males and sex females; age range 8-51 
years; mean age 15.1 years; SD 10.5 years), with AS, diagnosed by the ICD-10/DSM-IV, 10 of 35 
had ADHD. Further analysis based on two age groups, pre-adolescents (6-12 years, n=20) and 
adolescents (13 years and over, n=15), revealed that 50% of the younger age group had a diagnosis 
of ADHD, while in the latter group eight of 15 had ADHD (Ghaziuddin et al. 1998). The authors 
themselves point out that the validity of the conclusion from this study can only be judged on the 
basis of total population studies, but refer to Ehlers and Gillberg (1993) who in their study found 
that four of five definitive AS cases also had ADHD. According to Chaziuddin and co-workers 
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(1998), it is possible that children with AS are sometimes misdiagnosed with ADHD because of 
their social oddness and intrusiveness. In addition, caregivers may sometimes report attentional
problems such as social deficits. From a clinical standpoint, the children with ADHD should also 
be carefully screened for AS.   
5.4.4 TICS AND TOURETTE SYNDROME 
Tourette syndrome is a neuropsychiatric disorder characterised by involuntary, rapid, sudden body 
movements (tics) and uncontrollable vocalisations (tics) that occur repeatedly in the same way 
(Gillberg and Billstedt 2000). Persons with AS frequently exhibit repetitive movements 
(stereotypies) and can have motor and phonic tics (Ringman and Jankovic 2000). Ringman and 
Jankovic (2000) presented 12 persons (4 females, 8 males, age 3-32) with autism spectrum 
disorders (based on DSM-IV), of whom eight persons met the diagnostic criteria for AS. Of these, 
six met the diagnostic criteria for Tourette syndrome. In the epidemiological study by Ehlers and 
Gillberg (1993), 20% of the children in the study met the full criteria for Tourette syndrome and, in 
the study by Kadesjö and Gillberg (2000) (409 seven-year-old children in a one-year birth cohort), 
10% of children with Tourette syndrome also had AS. The clinical result of their study was that the 
impulsivity shown by the children with Tourette syndrome contributed more to their being 
"regarded" as having ADHD or AS than would be the case in the "average" individual diagnosed 
with ADHD or AS. Prototypical cases with these diagnoses would be considered mainly as ADHD 
or primarily affected by a decreased capacity to empathise with the perspectives of other people 
(AS) (Kadesjo and Gillberg 2000). In the previously mentioned study, Ghaziuddin and co-workers 
(1998) found that one person in 35 with AS also had Tourette syndrome and one tics. It is possible 
that Tourette syndrome has hitherto been underdiagnosed in cases with PDD simply as a function 
of tics being misdiagnosed as stereotypies and repetitive behaviours believed to be an inherent part 
of the autistic symptomatology. 
5.4.5 EATING DISORDERS 
According to Gillberg and co-workers (1996), Gillberg and Billstedt (2000) and Ahearn and co-
workers (2001), special eating habits are involved in autism; they include particular food refusal, 
food fads, pica, hoarding, overeating and various degrees of anorectic behaviour, including 
complete food refusal and compulsive ordering of food on the plate. According to Ahearn and co-
workers (2001), over 50% of children with autism spectrum disorders displayed selective eating. 
The studies linking AS and anorexia nervosa have given diverging results. Nilsson and co-workers 
(1996) proposed that anorexia nervosa may be just one of the ritualistic phenomena expressed by 
an individual with lifelong autism spectrum disorders. In a community-based controlled follow-up 
study consisting of 51 representative anorexia nervosa cases (48 females and 3 males), 18% 
(10/51) had an autism spectrum disorder, 4% (4/51) autism, 6% (6/51) AS and 8% atypical autism, 
both at the time of onset of the eating disorder (around 15 years of age) and five and 10 years later 
(Gillberg et al. 1996).  
According to Bölte and co-workers (2002), who studied 103 individuals with autism or AS (74 
males and 29 females; 10.1-39.9 years, mean 19.7; SD 7.8), the low or reduced body weight in AS 
was partly mediated by hyperactivity or was confounded by hyperactivity. The opposite conclusion 
was reached by Hebebrand and co-workers (1997) (13 individuals with AS; all males; mean age 
16.2; range 7.7-20.4 years) and Sobanski and co-workers (1999) (36 males; mean 12.3+3.5 years; 
range 7.0-18.8), who reported an over-representation of low body weight in AS.  
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5.4.6 ALEXITHYMIA 
Alexithymia is defined as having a restriction in the ability to identify and describe feeling states 
(Råstam et al. 1997, Nilsson et al. 1999, Tani et al. 2004). These features also characterise 
individuals with AS. Tani and co-workers (2004) showed that 20 AS subjects (age 27.2+7.3) were 
significantly more alexithymic than 20 age-matched controls. In the AS group, the subjective sleep 
quality was inferior, but this was not explained by alexithymia, or depressive symptoms.
Interestingly, there is an association between anorexia nervosa and autism spectrum disorders; as 
Råstam and co-workers in their study (1997) of 48 individuals with anorexia nervosa (45 females 
and 3 males; mean age 14.3 years; CI 13.9-14.7) found an anorexia nervosa subgroup with social 
interaction problems with particularly high scores on the 20-item Toronto Alexithymia Scale 
(TAS-20). It is important to identify the subgroup of anorexia nervosa cases with concomitant, 
chronic OCD or autism spectrum disorders, as they tend to have a poorer overall outcome. They 
would benefit from a treatment approach tailored to the needs of individuals with autism-spectrum 
disorders (Råstam et al. 1997).
5.4.7 OBSESSIVE-COMPULSIVE DISORDER (OCD) 
The symptomatology of OCD described in the DSM-IV (APA 1994) is strikingly similar to that of 
autistic psychopathy as portrayed by Hans Asperger himself (1944).  
Table 11. Diagnostic criteria for obsessive-compulsive disorder (DSM-IV) (APA 1994) 
A. The person exhibits either obsessions or compulsions obsessions are indicated by the following:
1. The person has recurrent and persistent thoughts, impulses, or images that are experienced, at some time during the 
disturbance, as intrusive and inappropriate and that cause marked anxiety or distress  
2. The thoughts, impulses, or images are not simply excessive worries about real-life problems  
3. The person attempts to ignore or suppress such thoughts, impulses, or images or to neutralize them with some other 
thought or action  
4. The person recognizes that the obsessional thoughts, impulses, or images are a product of his or her own mind (not 
imposed from without as in thought insertion)  
Compulsions are indicated by the following:  
1. The person has repetitive behaviours (e.g. hand washing, ordering, checking) or mental acts (e.g. praying, counting, 
repeating words silently) that the person feels driven to perform in response to an obsession or according to rules that 
must be applied rigidly  
2. The behaviours or mental acts are aimed at preventing some dreaded event or situation; however, these behaviours 
or mental acts either are not connected in a realistic way with what they are designed to neutralize or prevent or are 
clearly excessive.  
B. At some point during the course of the disorder, the person has recognized that the obsessions or compulsions 
are excessive or unreasonable. (Note: this does not apply to children). 
C. The obsessions or compulsions cause marked distress, are time consuming (take more than one hour a day), 
or significantly interfere with the person's normal routine, occupational/academic functioning, or usual social 
activities or relationships. 
D. If another axis I disorder is present, the content of the obsessions or compulsions is not restricted to it (e.g. 
preoccupation with drugs in the presence of a substance abuse disorder). 
E. The disturbance is not due to the direct physiologic effects of a substance (e.g. drug abuse, a medication) or a 
general medical condition. 
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Moreover, when examining the diagnostic criteria for OCD and AS, there are many similarities 
between OCD (Table 11) and the ritualistic and repetitive behaviours typical of AS. 
The difficulty is how to separate these two disorders or to decide whether or not they should be 
separated at all. This question has been addressed by two research groups (Tantam 2000, Martin et 
al. 2000), the first stating that resistance to rituals may be a distinguishing feature, as it is usually 
much less pronounced in AS than in OCD (Tantam 2000). The difference, according to Martin and 
co-workers (2000), is that the syndromes can be distinguished on the basis of their repetitive 
thought and actions. Rituals in AS are usually comforting and they may be preceded by mounting 
pleasurable excitement, whereas the compulsive rituals seen in OCD are preceded by anxiety 
(Martin et al. 2000). In the review by Martin and co-workers (2000), two obsession variables 
(aggression and symmetry) and five compulsion variables (checking; counting; hoarding; need to 
touch; tap, or rub; and self-damaging or self-mutilating behaviours) served maximally to separate 
AS and OCD measured by discriminant function analysis of the Yale-Brown Obsessive 
Compulsive Scale Symptom checklist. 
5.4.8 MUTISM 
In selective mutism, the child will speak, but only in certain situations, such as at home. The 
principal problem in children with selective mutism appears to be anxiety. This anxiety, which 
causes avoidance, seems closest to the definition of social anxiety disorder (social phobia) 
(Dummit et al. 1997). In a population-based study of selective mutism Kopp and Gillberg (1997), 
seven children (seven-year-olds to 15-year-olds) in two school districts of Göteborg, Sweden, were 
screened for selective mutism by their teachers and follow-up was achieved for a full school year. 
Three girls and two boys met the DSM-IV criteria for selective mutism and a further 25 had a 
combination of shyness and reticence that did not amount to a clinical disorder. Another conclusion
of the study was that one girl of five school-age children with selective mutism also met the full 
diagnostic criteria for AS. In the review by Gillberg and Billstedt (2000), all the studies referred to 
there account for a co-morbidity of AS and selective mutism, but they conclude that, in order to 
obtain more knowledge about these conditions being co-morbid, more studies are needed.
5.5 NEUROIMAGING  
5.5.1 MRI
There is growing interest in AS and neuroimaging, but so far the studies have mainly dealt with 
autism and HFA. Magnetic resonance imaging (MRI) is the method of choice for in vivo and non-
invasive investigations of human brain morphology in children and adolescents. The review by 
Shoumitro and Thompson (1998) reported structural and functional neuroimaging in autism. The 
results were that various findings were reported; such as increased brain volume and structural 
abnormality in the frontal lobe and corpus callosum in a proportion of autistic individuals 
(Shoumitro and Thompson 1998). In another review by Brambilla and co-workers (2003), all the 
MRI research papers involving individuals with autism, published from 1966 to May 2003, were 
reviewed in order to elucidate brain anatomy and the development of autism and were rated for 
completeness using a 12-item checklist. Increased total brain, parieto-temporal lobe and cerebellar 
hemisphere volumes were the most extensively replicated abnormalities in autism. The findings 
also suggested that the size of the amygdala, hippocampus and corpus callosum might be reduced 
in size. Brambilla and co-workers (2003) concluded that it is conceivable that abnormalities in the 
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neural network involving the fronto-temporo-parietal cortex, limbic system and cerebellum may 
underlie the pathophysiology of autism and that such changes could result from abnormal brain 
development during early life. Despite the fact that there were five years between the reviews by 
Shoumitro and Thompson (1998) and Brambilla and co-workers (2003), the anatomical changes 
reported for autism remained the same. 
Courchesne and co-workers (2001) quantified developmental abnormalities in cerebral and 
cerebellar volume in autism. The authors studied 60 autistic and 52 normal boys (aged 2 to 16 
years) using MRI. Thirty autistic boys were diagnosed and scanned when they were five or older. 
The other 30 were scanned between the age of two and four years and were then diagnosed with 
autism at least 2.5 years later, at an age when the diagnosis of autism is more reliable. Neonatal 
head circumferences from clinical records were available for 14 of 15 autistic two- to five-year-
olds and were on average normal (35.1 + 1.3 cm versus clinical norms: 34.6 + 1.6 cm) at birth, 
indicating normal overall brain volume up to that age, as only one measurement was above the 
95th percentile. By the age of two to four years, 90% of autistic boys had a brain volume larger 
than the normal average and 37% met the criteria for developmental macrencephaly. Autistic two- 
to three-year-old children had more cerebral (18%) and cerebellar (39%) white matter and more 
cerebral cortical grey matter (12%) than healthy controls, whereas older autistic children and 
adolescents did not have such enlarged grey- and white-matter volumes. In the cerebellum, autistic 
boys had less grey matter, a smaller ratio of grey to white matter and smaller vermis lobules VI-VII 
than normal controls. The conclusion was that the abnormal regulation of brain growth in autism 
results in early overgrowth followed by abnormally slowed growth. Hyperplasia was present in 
cerebral grey matter and cerebral and cerebellar white matter in early life in patients with autism 
(Courchesne et al. 2001). 
The literature does not contain any controlled series of brain MRI consisting exclusively of 
individuals with AS and the MRI studies of HFA are few in number. Hashimoto and co-workers 
(1993) found that the midbrain and medulla oblongata were significantly smaller in HFA than in 
controls. They studied 12 HFA subjects (11 males, 1 female; mean age 6.1 + 3.2 years); the control 
group consisted of children whose scans were performed for a diagnosis of headache or an 
evaluation of mild head trauma (21 males, 3 females; mean age 5.9 + 3.2 years) (Hashimoto et al. 
1993). They concluded that significant anatomical changes in the midbrain and medulla oblongata 
exist in HFA (Hashimoto et al. 1993).  
In a study by Schultz and co-workers (2000), the volume of the brain stem and cerebellum was 
measured, together with the cross-sectional area of the cerebellar vermis. The sample consisted of 
15 male persons with AD (age 22 + 10), 22 male persons with AS (age 19 + 12) and 12 male 
persons with PDD-NOS (age 15 + 11) and 39 age-matched controls (age 22 + 10). Comparisons of 
the volume of the cerebellum, midbrain, pons and medulla oblongata and area measurements of the 
cerebellar vermis and its conventional subdivisions failed to reveal any significant group 
differences. The authors suggest that the posterior fossa and its morphology are not related to the 
pathobiology of AS (Schultz et al. 2000). There is also an AS case report by Schultz and co-
workers (2000) describing a father and his son displaying almost identical areas of dysmorphology 
of the dorsolateral prefrontal cortex in both hemispheres.  
In an MRI study, Lotspeich and co-workers (2004) sought (1) to determine whether low-
functioning autism (LFA; IQ<70), high-functioning autism (HFA; IQ>70) and AS constituted 
distinct biological entities as evidenced by neuroanatomical measurements and (2) to assess 
intersite differences. In this case-control study, participants were recruited and underwent scanning 
at two academic medicine departments. Participants included four age-matched groups of volunteer 
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boys aged 7.8 to 17.9 years (13 patients with LFA, 18 with HFA, 21 with AS and 21 control 
subjects) and three volunteer adults for neuroimaging reliability. The main outcome measures 
included volumetric measures of total, white and grey matter for cerebral and cerebellar tissues. As
a result, intersite differences were seen for subject age, IQ and cerebellum measures. Cerebral grey-
matter volume was enlarged in both HFA and LFA compared with controls (p = 0.009 and p = 0.04 
respectively). Cerebral grey-matter volume in AS was intermediate between that of HFA and 
controls, but the difference was statistically non-significant. Exploratory analyses revealed a 
negative correlation between cerebral grey-matter volume and performance IQ in HFA but not in 
AS. A positive correlation between cerebral white-matter volume and performance IQ was 
observed within AS but not in HFA. It was concluded that the lack of replication between previous 
autism MRI studies could be due to intersite differences in MRI systems and the subjects' age and 
IQ. Cerebral grey-tissue findings suggest that AS is on the mild end of the autism spectrum. 
However, exploratory assessments of brain-IQ relationships revealed differences between HFA and 
AS, indicating that these conditions may be neurodevelopmentally different when patterns of 
multiple measures are examined. Further investigations of brain-behaviour relationships are 
indicated to confirm these findings.
5.5.2 SPECT, PET, fMRI, and NMR 
Single Photon Emission Computed Tomography (SPECT) is a nuclear medicine method, which 
visualises cerebral blood flow and indirectly visualises brain activity. SPECT is used as a research 
tool and rarely as a diagnostic tool. In a SPECT analysis, the functional activation of regions of 
interest and dopamine receptors, especially D2 receptors, is investigated. Functional Magnetic 
Resonance Imaging (fMRI) is a technique for determining the parts of the brain that are activated 
by different types of physical sensation or activity, such as sight, sound or the movement of a 
subject's fingers. This "brain mapping" is achieved by setting up an advanced MRI scanner in a 
special way so that the increased blood flow to the activated areas of the brain shows up on MRI 
scans. Positron emission tomography (PET, PET imaging, PET scan) is based on tracers labelled 
with positron-emitting isotopes. The reaction of the positrons in tissue (annihilation) creates two 
gamma photons emitted in opposite directions and detected by scintillation crystals. Many 
biological compounds or pharmaceuticals can be labelled with these isotopes. These numerous 
tracers can be used to image different functions of the human body. Nuclear Magnetic Resonance 
Spectroscopy (NMR) involves the absorption of radio frequency radiation by atomic nuclei in an 
applied magnetic field. Any atomic nucleus, which possesses either an odd mass, an odd atomic 
number, or both has spin angular momentum and a magnetic moment. Subsequent views/images of 
the human body are used to evaluate different functions. Most of the neuroimaging studies in 
autism spectrum disorders have focused on autism, while only a few have focused on AS and most 
of them have used a ToM stimulus in the PET investigation.  
In a small study of three persons with AS (two males and one female, ranging from 12 to 16 years 
of age), McKelvey and colleagues (1995) used SPECT and revealed consistent evidence of 
abnormal right-hemisphere dysfunction. They demonstrated right-hemispheric abnormalities in 
each subject: right temporal hypoperfusion with a central area of increased perfusion along with 
frontal polar hyperperfusion in one; diffusely decreased right-hemispheric uptake in the second; 
and reduced frontal and occipital uptake in the third. Cerebellar abnormalities were also present: a 
smaller right hemisphere with increased uptake in the first; reduced uptake in the vermis and right 
hemisphere in the second; and reduced vermal uptake in the third. According to the authors, the 
findings support the hypothesis that the neurobiological basis of AS is a developmental 
abnormality of the right cerebral hemisphere (McKelvey et al. 1995). 
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Chugani and co-workers (1997) used PET to study eight children with autism (7 boys, 1 girl; ages 
4.1 -11.1 years; mean age 6.6 years) and five of their non-autistic siblings (4 boys, 1 girl; ages 8.2–
14.4 years; mean age 9.9 years) to determine changes in serotonin synthesis in the brain. All seven 
boys displayed a unilateral reduction in serotonin synthesis in the frontal cortex and thalamus 
associated with increased serotonin synthesis in the contralateral dentate nucleus of the cerebellum. 
The girl with autism displayed no asymmetry in the PET scan. According to the authors, the 
serotoninergic abnormalities in the brain pathway, which is important for language production and 
sensory integration, may represent one mechanism underlying the pathophysiology of autism 
(Chugani et al. 1997). 
In a PET study, Happe and co-workers (1996) demonstrated a lack of activity in the left premedial 
cortex (the border between Brodmann’s areas 8 and 9) in ToM tasks in five right-handed AS males 
(age range 20-27 years; mean age 24). The comparison group was that used by Fletcher and co-
workers (1995), consisting of six right-handed male volunteers (age range 24-65 years; mean age 
38). In that group of healthy controls, the left medial prefrontal cortex (Brodmann’s areas 8, 9) was 
activated during mentalising stories in contrast to stories about physical events. In the study by 
Happe and co-workers (1996), an adjacent, more ventrally located area, Brodmann’s area 9/10, was 
activated in the five AS individuals.  
Castelli and co- workers (2002) studied 10 able adults with autistic disorder or AS (mean age 33 
years; SD = 7.6) and 10 normal volunteers (mean age 25 years; SD = 4.8), who were PET scanned 
while watching animated sequences. The animations depicted two triangles moving about on a 
screen in three different conditions: moving randomly, moving in a goal-directed fashion (chasing, 
fighting) and moving interactively with implied intentions (coaxing, tricking). The last condition
frequently elicited descriptions in terms of mental states that viewers attributed to the triangles 
(mentalising). The autism group gave fewer, less accurate descriptions of these latter animations 
but equally accurate descriptions of the other animations compared with controls. While viewing 
animations that elicited mentalising, in contrast to randomly moving shapes, the control group 
displayed increased activation in a previously identified mentalising network (medial prefrontal 
cortex, superior temporal sulcus at the temporo-parietal junction and temporal poles). The autism 
group displayed less activation than the normal group in all these regions. However, one additional 
region, the extrastriate cortex, which was highly active when watching animations that elicited 
mentalising, showed the same amount of increased activation in both groups. In the autism group, 
this extrastriate region showed reduced functional connectivity with the superior temporal sulcus at 
the temporo-parietal junction, an area associated with the processing of biological motion as well as 
with mentalising. This finding suggests a physiological cause for the mentalising dysfunction in 
autism: a bottleneck in the interaction between higher-order and lower-order perceptual processes 
(Castelli et al. 2002).
In another experiment, Baron-Cohen and co-workers (1999) tested six individuals with HFA or AS 
(four male and two females; age 26.3 + 2.1) and 12 controls (six males and six females, age 25.5 +
2.8) using fMRI, where the test subjects had to judge from the expressions of another person’s eyes 
what that other person might be thinking or feeling. They demonstrated increased activation in the 
frontotemporal regions but not in the amygdala in the persons with AS when comparing them with 
healthy controls. They interpreted their results as providing support for the social brain theory of 
normal function and the amygdala theory of autism (Baron-Cohen et al. 1999). fMRI has been used 
to study the role of temporal cortices in face and object recognition in people with autism spectrum 
disorders and AS. Referring to the review by Schultz and co-workers (2000), the conclusion so far 
relating to the studies using fMRI indicates that people with autism spectrum disorders/AS 
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(combined) demonstrate reduced activation in the fusiform gyrus (FG), the portion of the brain 
associated with facial recognition, and increased activation of adjacent portions of the brain (i.e. 
ITG; inferior temporal gyrus) associated with the recognition of objects. ITG was the region that 
showed the greatest activity when controls performed the object discrimination task. According to 
Schultz and co-workers (2000), subjects appear to be using “object region” for processing faces. 
The same review also stated that, in AS and autism spectrum disorders, there is a significant 
reduction in activity in the middle temporal gyrus as compared to the controls. The importance of 
this is that this area appears to be specific for evaluating facial expressions/or direction of eye gaze, 
suggesting that there is a larger system that is important for reading emotional displays (Schultz et 
al. 2000).
In the study by Öktem and co-workers (2001), nine children with AS and eight controls were 
studied using fMRI during a task involving social judgement. All the controls and five of the nine 
subjects with AS displayed signal intensity changes in frontal regions. Four individuals with AS, 
including one case with right frontal dysplasia, displayed no signal intensity change during the 
task. According to the authors, this first fMRI study of childhood AS demonstrated some 
differences in frontal activation patterns between individuals with AS and normal subjects (Öktem 
et al. 2001).
Murphy and co-workers (2002) used in vivo proton magnetic resonance spectroscopy to examine 
the neuronal integrity of the medial prefrontal and parietal lobes in 14 non–learning-disabled adults 
with AS (mean 30 years; SD 9 years; 10 subjects right handed and 4 left handed) and 18 control 
subjects  (mean 32 years; SD 8 years; 14 right handed, 4 left handed) matched for gender, age and 
IQ. They obtained measurements of the prefrontal lobe in 11, the parietal lobe in 13 and both lobes 
in 10 subjects with AS. They measured the concentrations and ratios of N-acetylaspartate (NAA), 
creatine and phosphocreatine (Cr + PCr) and choline (Cho). The levels of NAA, Cr + PCr and Cho 
are indicators of neuronal density and mitochondrial metabolism, phosphate metabolism and 
membrane turnover. Frontal metabolite levels were correlated with scores on the Yale-Brown 
Obsessive Compulsive Scale and the Autism Diagnostic Interview (ADI). The result was that 
subjects with AS had a significantly higher prefrontal lobe concentration of NAA (z = -3.1; p = 
0.002), Cr + PCr (z = -2.2; p = 0.03) and Cho (z = -2.9; p = 0.003). An increase in the prefrontal 
NAA concentration was significantly correlated with obsessional behaviour ([tau] = 0.67; p =
0.005); while an increase in the prefrontal concentration of Cho was correlated with social function 
([tau] = 0.72; p  = 0.02). Murphy and co-workers (2002) found no significant differences in parietal 
lobe metabolite concentrations. They concluded that subjects with AS had abnormalities in the 
neuronal integrity of the prefrontal lobe, which is related to the severity of clinical symptoms 
(Murphy et al. 2002). 
To summarise; in spite of the many neuroimaging studies in AS, there are still areas that have not 
yet been investigated by neuroimaging.  One of the most important fields that has stillnot been 
studied at all is receptor-specific alteration in AS, together with the dopamine-transported (DAT) 
alteration in the striatum. 
5.6 GENETICS 
Family and twin studies indicate that genetic factors play an important role in autism spectrum 
disorders. Based on epidemiological and family studies, the highest recurrence risk for close 
relatives of the affected individuals is in autism; the risk for a monozygotic pair of twins is as much
as 82% and that for a sibling 5-10% (Folstein & Rosen-Sheidley 2001).  
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Recent molecular genetic studies of autism and related disorders support a multilocus etiology for 
this disease spectrum (Auranen et al. 2003). Ten genome-wide scans have been performed in 
autism to assign predisposing genetic loci for autism spectrum disorders (IMGSAC, 1998, Barret et 
al. 1999, Philippe et al.1999, Risch et al. 1999, Buxbaum et al. 2001, Liu et al. 2001, IMGSAC 
2001a, Shao et al. 2002, Auranen et al. 2003, Yonan et al. 2003). Genome-wide scans have been 
performed in families with at least two "affected" siblings; the majority have been carried out in 
families with autism only; in some of them affected siblings with diagnoses of either AS or PDD 
have also been included. The most promising genetic loci have been assigned to chromosomes 2 
and 7q.
In the study by Auranen and co-workers (2002), 38 Finnish families were studied, including family 
members with autism, AS and dysphasia in the same set of families. The purpose of the study was 
to identify genetic loci for autism spectrum disorders with a two-stage, genome-wide scan. The 
most significant evidence for linkage was found on chromosome 3q25-27, with a maximum two-
point LOD score of 4.31 (Z(max )(dom)) for D3S3037 using infantile autism and AS as an 
affection status. Six markers flanking over a 5-cM region on 3q gave Z(max dom) >3, and a 
maximum parametric multipoint LOD score (MLS) of 4.81 was obtained in the vicinity of 
D3S3715 and D3S3037. Association, linkage disequilibrium, and haplotype analyses provided 
some evidence for shared ancestor alleles on this chromosomal region among affected individuals, 
especially in the regional subisolate. Additional potential susceptibility loci with two-point LOD 
scores > 2 were observed on chromosomes 1q21-22 and 7q. The region on 1q21-22 overlapped 
with the previously reported candidate region for infantile autism and schizophrenia, whereas the 
region on chromosome 7q provided evidence of linkage 58 cM distally from the previously 
described autism susceptibility locus (AUTS1). The highest two-point LOD score of 3.58 was 
obtained with D1S484 (Auranen et al. 2002). 
The same study group focused their molecular studies on families originating from a subisolate of 
central Finland. Genealogical studies enabled the identification of a megapedigree comprising 12 
core families with autism and AS. The group analysed two chromosomal regions on 1q and 3q, 
showing the highest LOD in the genome-wide scan, as well as the AUTS1 locus on chromosome 
7q. For markers on 3q25-27, more significant association was observed in families from the 
subisolate compared with families from the rest of Finland. In contrast, no clear evidence of an 
association on the AUTS1 locus was obtained. The wide interval showing association, on 
chromosome 3q in particular, suggests a locus for autism spectrum disorders in this chromosomal 
region (Auranen et al. 2003). 
Jamain and co-workers (2003) reported mutations in two X-linked genes encoding neuroligins 
NLGN3 and NLGN4 in siblings with autism spectrum disorders. These mutations affect cell-
adhesion molecules localised at the synapse and the study group suggested that a defect of in these 
neuroligins may abolish the formation, stabilisation or recognition of specific synapses essential for 
the communication processes that are deficient in individuals with autism spectrum disorders 
(Jamain et al. 2003).  
Two individuals with AS and balanced translocations t(13;17) and t(17;19) respectively were 
identified in a study by Tentler and co-workers (2003). Fluorescent in situ hybridisation (FISH) 
analysis with chromosome 17-specific clones to metaphase chromosomes from both patients 
revealed that the chromosome 17 breakpoints are located within a 300 kb region at 17p13. The 
region spans 14 known genes. The close physical relationship of the two 17p breakpoints suggested 
a common genetic aetiology for the phenotype in the persons with AS. Structural and functional 
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analysis of the genes located around the two 17p breakpoints in t(13;17) and t(17;19) persons may 
reveal candidate sequences for the AS phenotype according to Tentler and co-workers (2003).  
To summarise, in spite of the clear genetic basis of AS with a high recurrenc e frequency, according 
to the genetic studies in which individuals with AS have been involved, it appears that there are a 
few susceptibility chromosomes for the etiological factor for AS. 
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6. AIMS OF THE STUDY  
As evidenced by the somewhat conflicting data relating to clinical delineation and occurrence, 
Asperger syndrome has not yet been satisfactorily established as a clinical entity. A broad-based 
collaborative research project was therefore launched in Helsinki in 1999 with the aim of 
approaching the autism spectrum disorder utilising the clinical data, neuroimaging, 
neuropsychology and molecular genetics. A subproject in this large project, which is the present 
thesis, focused on the following questions. 
Are there clinical features in Asperger syndrome, other than those included in theICD-10 and 
DSM-IV, which are of importance for an understanding of this syndrome? 
Are there neuroimaging findings typical of Asperger syndrome? 
Does the combination of clinical findings, neuroimaging and molecular genetics provide any basis 
for understanding the underlying pathogenesis? 
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7. SERIES – SUBJECTS  
In the spring of 2004, the total clinical autism spectrum disorder series collected by the Helsinki-
based research consortium comprised 250 families (1,360 individuals). The founding units of the 
research consortium were the Department of Child Neurology, University of Helsinki, and the 
Departments of Molecular Genetics at the Institute for Public Health in Helsinki and at the 
University of Helsinki, together with the Clinical Brain Research Unit at the University of 
Helsinki. 
The families in the subgroup of 29 families with AS were recruited via the Hospital for Children 
and Adolescents, Department of Child Neurology, Helsinki University Central Hospital, the 
Helsinki Asperger Center, the Medical Center Dextra and the central Finnish hospitals. In the 
subgroup of 29 families with AS, the diagnostic procedures were carried out uniformly. The 
diagnosis was only settled after agreement in the group responsible for the diagnostic procedure. 
The principal author (TNvW) either saw all the individuals personally, or reviewed all the data and 
documentation collected for the diagnostic process. The group responsible for the diagnostic 
procedures consisted of two child neurologists, two neuropsychologists and two registered nurses, 
all of whom had special training in and vast experience of the diagnostic procedures for autism-
spectrum disorders.
The participants in the studies included in this thesis were recruited from these 29 families (Table 
12).
Table 12. Overlap of patient series in the original papers 
Paper I Paper II Paper III Paper IV    Paper V 
  (Clinical) (MRI) (PET-ToM) (PET-DOPA)   (Genetics)  
Paper I   
(Clinical)  138 4 4 4    72 
Paper II  4 28 4 4    4 
(MRI) 
Paper III  4 4 8 8    4 
(PET-ToM) 
Paper IV  4 4 8 8    4 
(PET-DOPA)  
Paper V  72 4 4 4    119 
(Genetics) 
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One underlying concept in the present set of studies and in the activities of the research consortium 
in general was to study the same population using a large set of methods and, at the same time, 
make an effort to secure the comparability of the results of different investigations. 
7.1 THE CLINICAL STUDY (I)  
The Asperger family series from the large autism spectrum series was recruited through the 
Hospital for Children and Adolescents, Department of Child Neurology, Helsinki University 
Central Hospital (HUCH), and the Helsinki Asperger Center (HAC), the Medical Center Dextra, 
Helsinki Finland. The Department of Child Neurology at the Helsinki University Central Hospital 
primarily serves the catchment area of the Helsinki University Central Hospital (population 1.4 
million), but it is also a tertiary referral unit serving the entire country. The HAC is a private clinic, 
freely available to anyone and serving the whole of Finland (population 5.2 million).  
The Asperger clinical series consisted of 29 families, in which AS was present in at least two 
generations. From this total series 10 large families, in which the diagnosis was present in at least 
two generations, exclusively on either the maternal or the paternal side, and for which molecular 
genetic data had also been obtained (Ylisaukko-oja et al. 2003), were recruited for the present 
analysis, after giving their informed consent. These ten families consisted of 138 persons, of whom 
58 individuals, using a subsequently outlined diagnostic procedure, were found to have a 
confirmed diagnosis of AS (range 4.5-78.2 years; mean 32.8 years; SEM 2.8; CI 27.1-38.5). 
Another 56 (range 3.5–77.9 years; mean 33.8 years; SEM 2.6; CI 28.2-38.5) also went through the 
diagnostic procedure and were found not to fulfil the criteria for AS. The remaining 24 family 
members could not be included in the study, as four lived abroad and the others would not agree to 
participate. This means that 83% of the family members participated.  
7.2 THE MRI STUDY (II) 
A subgroup of 17 children and adolescents (3 girls and 14 boys; age 6-19 years; mean 12.4 years) 
with AS among from those referred to the unit of Child Neurology at the Helsinki University 
Central Hospital for diagnosis and rehabilitation and who gave their consent to participate were 
recruited between January 1999 and May 1999 for the MRI study (II). During the same period, 11 
adults (4 women and 7 men with AS; age 20-60 years; mean 37.9 years) were recruited for this 
study from those who visited the Helsinki Asperger Center, Medical Center Dextra, Helsinki, 
Finland, for a diagnostic evaluation and fulfilled the diagnosis of AS, which was made using the 
same procedure as that used at the hospital unit. In every case, the diagnosis was confirmed by the 
principal author (T N-vW). 
Individuals with medical conditions such as fragile-X syndrome, chromosomal aberrations and 
epilepsy, cerebral palsy, schizophrenia or neurocutaneous syndromes were excluded. A history of 
accompanying neuropsychiatric disorders such as depression and/or obsessive thoughts was not an 
exclusion criterion, but none of the persons in the study was taking any psychiatric medication at 
the time of the investigation. 
The entire series thus consisted of 28 individuals. There were two father and son combinations, 
where the first one was an adult/child combination and the other was an adult/adult combination. In 
the group of children and adolescents, there was one sister/brother combination.  
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The controls were healthy volunteers and they matched the Asperger individuals with respect to 
age and gender. There were seventeen children and adolescents, (3 girls and 14 boys; age 8-19 
years; mean 12.1 years) and 11 adults (4 women and 7 men with AS; age 23-62 years; mean 38.2 
years). 
7.3 THE PET STUDIES (III-IV) 
Theory of mind–PET study (III) 
The study subjects were eight otherwise healthy right-handed men with AS, apart from one who 
had a pacemaker (mean age 28.1 + 6.2; range 19.2–38.2 years), and they had not taken any 
medication for six months prior to the study. During the study, none of the subjects had any 
accompanying neuropsychiatric diagnosis. They were all recruited via the Helsinki Asperger 
Center, Medical Center Dextra, Helsinki, Finland. 
The controls were eight right-handed healthy male volunteers (mean 31.5 + 4.5; range 23.8–39.8 
years). In order to rule out the possible presence of Asperger traits or first-order relatives with 
autism spectrum disorders in the controls, the investigators interviewed all the controls. The two 
groups did not differ from each other with respect to age, social status or cognitive functions. All 
the participants were of Finnish ancestry and Finnish was their first language.  
FDOPA-PETstudy (IV) 
The study sample consisted of eight healthy men with AS (mean age 29.2 + 5.8 years) recruited 
from the Helsinki Asperger Center, Medical Center Dextra, Helsinki, Finland, who had not taken 
any medication six months prior to the study and, during the study, none of the subjects had any 
accompanying neuropsychiatric diagnosis. The controls were five healthy male volunteers (mean 
age 30.5 + 4.9), three of the controls were the same as in ToM-PET study and two were new. The 
two groups did not differ from each other with respect to age, social status or cognitive functions. 
All the participants were of Finnish ancestry. 
7.4 THE GENETIC STUDY (V) 
In all, 119 individuals, representing 17 families, were included in the molecular genetic analyses 
(Fig. 1). A pedigree was drawn of the families who gave their consent to participate in the genetic 
study. The families were selected according to the number of generations there were in the family, 
i.e. the inclusion criterion was the presence of AS in two or more generations in the family and 
exclusively on either the maternal or the paternal side. From these 10 large families, in which the 
diagnosis was present in at least two generations on exclusively either the maternal or the paternal 
side and for which molecular genetic data had been obtained, were recruited for the present 
analysis, after obtaining informed consent (Ylisaukko-oja et al. 2003). Informed consent was 
obtained from the participating individuals or their parents. 
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Table 13. Essential features of the families included in the molecular genetic analysis 
(V, Table 1). 
  Stage I Stage II 
      
      
Total number of families 13 17 
          Four-generation families 1 1 
          Three-generation families 11 13 
          Two-generation families 1 3 
      
Total number of individuals 93 119 
          Affected individuals, narrow classification (LC1) 62 72 
          Affected individuals, broad classification (LC2) 66 82 
      
Overlapping diagnoses:     
          Schizophrenia   3 
          Bipolar disorder   1 
Only individuals with normal cognitive development before three years of age were included in the 
study. Other autism spectrum disorders were not present in the families. One individual had a 
confirmed co-existing diagnosis of bipolar disorder and three AS individuals had schizophrenia. 
These diagnoses were based on the DSM-IV diagnostic nomenclature (DSM-IV). Thirty-nine per 
cent of the persons belonged to the paediatric age group (< 18 years of age). None of the families in 
the current Asperger data set has been included in the previous studies of autism spectrum 
disorders in the Finnish population (Auranen et al. 2002). 
Individuals fulfilling the criteria for AS according to the ICD-10 (n=72) were categorised as 
affected in the narrow diagnostic classification (liability class 1, LC1). Family members who had 
Asperger–like features but who did not fulfil all the diagnostic criteria (n=10) were included as 
affected individuals in a broad phenotypic category (liability class 2, LC2) (Table 13) (V, Table 1).
The primary screen was performed using 13 families (93 individuals) and the complete material 
comprising 17 families (119 individuals) was used in the second stage of the study (Table 13) (V, 
Table 1) (Fig. 1) (V, Fig.1). 
Genealogical studies were carried out according to methods described elsewhere (Varilo et al. 
1996). The families were interviewed for the dates and places of birth and their ancestors were 
traced from church records up to 1850 and from the National Archives of Finland for earlier 
periods.
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Fig. 1 Pedigrees for the 17 families in the genome-wide screen.
Molecular genetic analysis (V, Fig.1). 
Black symbols = Asperger syndrome, liability class 1; faded symbols = Asperger syndrome, 
liability class 2; Unfilled symbols = unaffected or data not available (unknown in the statistical 
analyses). Asterisks indicate the individuals whose DNA was not available for the analyses. 
Families 3, 7, 8 and 15 were only included in the second stage of the study. 
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8. ETHICAL ASPECTS 
All the subjects and controls were recruited after informed consent, which was obtained from the 
participating individuals or their parents. All the instructions about the studies were given in 
written form and the acceptance to participate was also written on a sheet of paper. The 
information material and the forms that were used were approved by the ethics committees. The 
participants were informed about the results of studies in which they had been taking part and they 
could contact any of the researchers at any time during the studies. The subjects and controls could 
withdraw from the studies at any time during the investigations without needing to give any 
explanations.  
The arterial infusion in the FDOPA-PET studies caused some pain (during the arterial iv bolus) and 
the subjects and controls were informed of this beforehand. The PET studies also had a minor 
radiation effect, one FDOPA study caused a 5-8.5mSv effective dose for the body, which was 
equal to the radiation a person normally receives from the atmosphere in the space of two years, so 
the radiation was not considered to be dangerous to the persons in question.  
The results of the study will benefit persons with Asperger syndrome both now and in the future.  
The Ethics Committees at the hospital approved the study for children and adolescents and the 
University of Helsinki, the Radiology Department at Helsinki University Central Hospital and the 
National Public Health Institute, Helsinki, Finland, Turku University and Turku University Central 
Hospital approved the study.  
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9. METHODS 
9.1 DIAGNOSTIC PROCEDURES 
9.1.1 THE CLINICAL STUDY (I) 
In the diagnostic procedure focus was on ICD-10 (WHO 1993) and DSM-IV (APA 1994) criteria 
for Asperger syndrome. In order to clarify which of the criteria full-filled basic information was 
collected using the following instruments. 
1. Asperger Syndrome Diagnostic Interview (ASDI) (Gillberg et al. 2001) is an investigator-based 
interview consisting of 20 items, which must all be covered in detail. The interviews were 
conducted in accordance with the principles of this instrument.
2. The Autism Diagnostic Observation Schedule (ADOS) (Lord et al. 2001) is a semi-structured, 
standardised assessment of communication, social interaction and play or the imaginative use of 
materials for individuals who have been referred because of possible autism spectrum disorders. 
3. The Autism Diagnostic Interview–Revised (ADI-R) (Lord et al. 1994) is an investigator-based 
interview containing structured coding for each behavioural item. It consists of six sections dealing 
with background orientation, developmental history and earlier and current behaviour. 
4. The Asperger syndrome related additional features questionnaire, which was constructed by the 
authors.
For this study, a set of questions (I, Table 1, Appendix I) were developed in order to determine 
whether there were any anamnestic data showing abnormalities in the domains of prosopagnosia, 
sensibility, eating habits, selection situations, hyperactivity/attention, diurnal rhythm and sleep, 
onset of puberty and external appearance. 
 In addition to this, available medical charts and other relevant documentation were scrutinised. 
The diagnosis was a consensus, with the diagnostic procedure being analogical for the persons who 
participated in the study. 
The procedure 
The above-mentioned instruments were used in the families which were recruited for this analysis. 
A thorough diagnostic interview according to the principles of the ASDI (Gillberg 2001) was 
carried out and one or several members of the diagnostic team saw the individuals. A final 
diagnosis was settled only after detailed scrutiny of the collected retrospective and diagnostic 
material. The diagnostic, structured interviews were videotaped for subsequent review. 
9.1.2 THE MRI STUDY (II) 
All the individuals included in the series underwent the same diagnostic procedure; as screening 
instruments (ASSQ) (Gillberg and Gillberg 1989, Ehlers 1999 et al.) if they were children or 
adolescents and (ASDI)(Gillberg et al. 2001) if they were adults. All the included individuals 
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fulfilled the diagnostic criteria for AS according to DSM-IV (APA 1994) and ICD-10 (WHO 
1993).
9.1.3. THE PET-STUDIES (III-IV) 
The diagnostic procedure consisted of a detailed, structured interview (ASSQ) according to the 
principles outlined by Gillberg and Gillberg (1989), Ehlers and Gillberg (1993) and Ehlers and co-
workers (1999), which was performed by the principal investigator. Both the person with AS and 
one parent or close relative were interviewed. Only individuals fulfilling the criteria of the DSM-
IV (APA 1994) and ICD-10 (WHO 1993), without any accompanying diagnoses or medication, 
were accepted for the study. All the available medical, neuropsychological and psychiatric reports 
were reviewed.  
9.1.4 THE GENETIC STUDY (V) 
The diagnostic procedure consisted of a detailed, structured interview, which was based on the 
ICD-10 (WHO 1993) and DSM-IV (APA 1994). In some cases, the (ASSQ) (Gillberg and Gillberg 
1989, Ehlers and Gillberg 1993, Ehlers et al. 1999) and (ASDI) (Gillberg et al. 2001) was used to 
support the diagnoses. Neuropediatricians or research nurses, who had long experience of autism-
spectrum disorders, conducted all the interviews. All the persons that had been seen and 
interviewed  by the research nurses were evaluated by the principal author. For the adults, reliable 
anamnestic information on development and behaviour in childhood was collected by means of 
structured interviews with one or several family members. The diagnostic interview also included 
questions on hypersensitivity to external stimuli, face blindness (prosopagnosia), motor clumsiness 
and sleeping and eating disorders, which are not diagnostic criteria but have been reported to be 
frequently present in individuals with Asperger syndrome.  
9.2 NEUROPSYCHOLOGICAL METHODS 
9.2.1 THE MRI STUDY (II) 
An experienced neuropsychologist (TK) performed the neuropsychological test battery, the WISC 
(Wechsler Intelligence Scale for Children) (Wechsler 1991) or WAIS (Wechsler Adult Intelligence 
Scale) (Wechsler 1981) or other standardised intelligence tests. All the participating individuals, 
apart from three children, had an IQ of more than 80 and they were attending ordinary schools. All 
the adolescents and adults had finished their education or were university students. 
9.2.2 THE PET STUDIES (III-IV) 
The test that was used was the WAIS-R (Wechsler Adult Intelligence Scale Revised) (Wechsler 
1981). In addition, the Asperger group was also given the WMS-R (Wechsler Memory Scale 
Revised) (Wechsler 1996), the WCST (Wisconsin Card Sorting Test), the Benton Face Recognition 
Test and the Face Recognition Task from the NEPSY (Neuropsychological Test Battery for 
Children). Neuropsychologist TK performed all these tests. 
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9.3 NEUROIMAGING METHODS 
9.3.1 MRI (II) 
Technical part 
All the individuals with AS underwent a 1.5T brain MRI. Fast spin-echo T2-weighted axial and 
coronal slice axial fluid attenuated inversion recovery (FLAIR) sequence and a three-dimensional, 
magnetisation-prepared, rapid acquisition gradient echo were obtained. T1-weighted sagittal slices 
(slice thickness 1 mm) covered the entire brain. The same imaging protocol was used in all but five 
of the controls. One child was imaged for other purposes and only T1-weighted sagittal images 
were therefore available. T2-weighted images (with various parameters) were missing in four adult 
control individuals.  
Visual analyses 
Two radiologists (T.A, O.S) made a joint evaluation of the images for:  
1. Cerebral cortical abnormalities  
2. Cerebral white-matter alterations (foci < 2 mm were excluded) 
3. Enlargement of cerebral CSF (cerebral spinal fluid) spaces  
4. Enlargement of cerebellar fissures and atrophy of vermis  
5. Enlargement in the size of CSF spaces within the posterior fossa 
Quantitative analyses  
In addition to visual analysis a total of 11 measurements were obtained (II, fig 1-3). The 
measurements were carried out by two raters irrespective of each other. The recordings were made 
twice for all the measurements and the results were standard mean. 
1. The midsagittal diameters of the genu (diameter 1) (Fig. 3), body (diameter 2) (Fig. 3) and 
    splenium (diameter 3) (Fig. 3) and the surface area of the corpus callosum were measured 
    from T1-weighted sagittal images  (Fig.  3) (Laissy et al. 1993). 
2. The anterior-posterior diameters of the brain stem were measured from midsagittal T1-weighted 
    images at the mesencephalon (diameter 4) (Fig.1), pons (diameter 5) (Fig.1) and medulla 
    oblongata (diameter 6) (Fig. 1) (Raininko et al. 1994).  
3. The anterior-posterior diameter (diameter 1) was also measured from an axial image of the 
    mesencephalon reconstructed from T1-weighted sagittal three-weighted images (Fig 2A-C). 
4. The horizontal diameter (diameter 2) was measured from an axial image of the mesencephalon 
    (Fig.2 A-C). The surface area was measured from an axial image of the mesencephalon (Fig. 2    
     D). 
5. The area of the cerebrum was measured from midsagittal images (Fig. 3). 
9.3.2 THE ToM-PET STUDY (III)  
Stimuli  
Test stories 
Three of the original “strange stories” developed by Happe (Happe 1994) were translated into 
Finnish (author TK). Of the four physical stories (Phys-stories), one was developed by Happe 
(Happe 1994) and the author TK designed the other three stories in accordance with the principles 
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outlined by Fletcher and co-workers (Fletcher et al. 1995). The Phys-stories were constructed to 
parallel the ToM-stories in that they required a conclusion beyond the information stated. Both 
story types shared the requirement of integrating information from the story sentences into a story 
structure, remembering and linking events and inferring an included element. The two sets of 
stories were designed to differ from each other only with respect to the requirement of mentalising.
Presentation of the stimuli
One of the Phys-stories was presented on a tape first for rehearsal without tracer injection and 
imaging. After that, each subject listened to the six stories in random order, but the order was the 
same for all the subjects and controls (when it came to the ToM-stories and Phys-stories). At the 
end of each story, a question dealing with the story was asked. The persons with AS and the 
controls were informed in advance that they were going to hear two types of story, but they were 
not informed in advance about the type of story they would hear next. After 30 seconds of 
consideration, the person answered the question aloud and the answer was recorded. The 
presentation of the story began at the same time as the 90-second data acquisition.   
The total length of the ToM questions, waiting time and answer were a mean of 78.8 s (SD 6.8) for 
the AS group and 76.0s (SD 6.6) for the controls, but the difference was not significant. The 
corresponding figures for the Phys-stories were 80,5 (SD 4,5) 77,8 (SD 5,4), respectively. The 
differences were not statistically different, and neither were there any differences when the length 
of ToM-tasks and Phys-tasks were compared within the two groups.  
Analysis of the answers to the questions related to the stories (ToM and Phys)
The answers to the ToM-tasks were analysed blindly by one of the authors (TK) in accordance with 
the original principles of Happe and co-workers (Happe et al. 1996). When analysed for 
correctness, all the answers were correct. For the mental aspect, a five-step scale (0-4) was used 
and summed (=sum score). The best score, 4, corresponded to “correct mental state justification”, a 
score of 3 to “vague but not incorrect mental state justification”, a score of 2 to “incorrect mental 
state justification”, a score of 1 to “correct physical state justification” and a score of 0 to 
“incorrect physical state justification”. All the mental state justifications, even the incorrect ones, 
indicated the existence of some theory of mind. So all the mental answers obtained higher scores 
than the correct physical state answers. The procedure for the Phys-stories was identical, but a 
three-step scale (0-2) was used. The best score, 2, corresponded to “correct physical state 
justification”, a score of 1 to “vague but not incorrect physical state justification” and a score of 0 
to “incorrect physical state justification”.    
Sum scores in the Asperger individuals and in the controls 
There were no significant differences between the control subjects (mean 9.6 + 1.3) and the AS 
(mean 10.4 ± 0.5) individuals when it came to the sum scores for the ToM stories or the Phys 
stories (AS individuals 5.6 ±1.1; controls 5.8 ± 0.7). 
Image acquisition 
The PET studies were performed using a twelve-ring PET scanner (Advance General Electric 
Medical Systems, Milwaukee, WI) (GE), producing 35 image slices with an interslice distance of 
4.25 mm and an in-plane resolution of 6.5 mm. The total axial field of view was 15 cm, permitting 
imaging of the entire brain. Head movements were minimised using a commercial head holder 
(GE) and scanning was performed in the cantomeatal line. An eight-minute transmission scan for 
attenuation correction was performed before the start of the activation studies. An intravenous 
bolus of 200 MBq of H2O15 was injected into the right antebrachial vein using a semiautomatic 
dosing system. The data were gathered in the 3D acquisition mode for a period of 90 seconds with 
 50 
an interscan interval of eight minutes. The emission data acquisition was started when the true 
coincidence rate increased by 15 kilocounts per second (kcps). LM, PhD, MD performed all the 
PET investigations.  
Statistical analysis of the imaging data  
Image pre-processing 
The PET data pre-processing and statistical analysis was performed using Statistical Parametric 
Mapping software version 1999 (SPM99) (Friston et al. 1995) and Matlab 5.3 for Windows. 
Movement correction of the images was performed using sinc interpolation for re-slicing the 
images and the mean image of the realigned images was used in the spatial normalisation of the 
images, which was done to the standard PET template using an SPM default algorithm. Finally, 
images were smoothed using a Gaussian filter of 10 mm full width at half maximum (FWHM).  
ToM stories versus Phys stories 
The differences in regional cerebral blood flow (rCBF) effects between the ToM-stories and Phys- 
stories were first tested separately for the AS group and the control group. A single-group 
multisubject conditions and covariates design was used with default settings. The effects of 
differences in global cerebral blood flow (gCBF) were eliminated by proportional scaling 
normalisation and the mean voxel values were scaled to 50. Imaging data and model specifications 
resulted in a model with 10 parameters and 39 degrees of freedom. The differences were analysed 
using t-contrasts for both directions (ToM-Phys, Phys-ToM). Voxels were considered to be 
significant if their p-values were below 0.05 after correction for multiple comparisons. In order to 
establish whether the reason for the disagreement in results between our study and previous ones 
was the strict statistics in the analysis of the present study, an additional analysis using more liberal 
statistics was performed using a cluster extent threshold of 340 voxels corresponding to a cluster 
level uncorrected p-value of 0.05.  
Analysis with the frontal mask
An additional ‘volume of interest (VOI)’-based analysis of the frontal areas was performed in order 
to enhance the sensitivity of the analysis (ToM-Phys). The VOI comprising 14,801 voxels was 
drawn using Imadeus software (Forima Inc, Turku, Finland) and the statistical analysis was made 
using the small volume correction (SVC) of SPM99 (Friston et al. 1995).  
Analysis of group by task interaction 
The differences in the activation pattern between the ToM-tasks and the control tasks between the 
AS group and the control group were performed using random-effects analysis (RFX). The 
contrasts for each subject were written to subject-specific contrast images serving as the first, 
within-subject stage of RFX. Secondly, for the between-subjects stage of RFX, the effect in 
contrast images was statistically tested using an independent samples t-test using the Statistical 
non-Parametric Mapping 99 software (SnPM99) (Nichols and Holmes 2001). A corrected p-value 
of 0.05 was applied. In the analysis, variance smoothing of 15 mm and 1,000 permutations were 
used. The corresponding pseudo-t height threshold was 4.74. 
Group comparisons 
A comparison of the overall activation patterns between the persons with AS as a group and the 
controls as a group was made. Three analyses were performed; (1) the PET images of all stories 
(ToM and Phys) together, (2) the PET images of the ToM - stories and (3) the PET images of the 
Phys stories. For these analyses, three averaged PET images for each subject were calculated using 
the SPM99 ImgCalc procedure, firstly over all the pre-processed PET images of a single subject 
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and secondly over all the PET images of a single subject related to the ToM stories and to the Phys 
stories separately. (Only the results using all the images are shown, but the results (subject with 
AS–controls) were similar in all the analyses. The groups were compared using a one-scan-per-
subject design with default settings. The effects of variation in the rCBF were eliminated by 
Analysis of Covariance global normalisation. The mean voxel values were scaled to 50. The AS 
group and the control group were compared using t-contrasts for both directions (control group-AS 
group, AS group-control group). The results were considered to be significant if the uncorrected p-
value was below 0.05. 
9.3.3 THE FDOPA-PET STUDY (IV) 
PET data acquisition and analysis 
[18F]FDOPA was produced according to previously published methods (Namavari et al. 1992, 
Bergman et al. 1995). The average specific radioactivity of [18F]FDOPA was 2.12 + 1.36 
GBq/umol at the time of the injection. The PET studies were performed using a twelve-ring GE 
Advance PET scanner (General Electric Medical Systems, Milwaukee, WI) (35 image slices, 
interslice distance of 4.25 mm, in-plane resolution of 6.5 mm). An eight-minute transmission scan 
for attenuation correction was performed before the scan. Partial volume correction was not made. 
The study subjects (4 AS subjects and all the controls) received a 150 mg dose of carbidopa before 
the PET study (having no theoretical influence on the Ki values using the analysis method in 
question nor causing actual differences in the present AS group). An intravenous bolus of 180 MBq 
of [18F]FDOPA (range 164-199) was injected into the right antebrachial vein. The injected amount 
of [18F]FDOPA was 27.0 +17.8 ug on average. The data were gathered in the 3D acquisition mode 
for a period of 60 minutes in 20 frames. A total of 27 arterial plasma samples were gathered for the 
plasma radioactivity curve. The total plasma radioactivity concentration was measured with a well 
counter. The ratio of radioactive metabolites was analysed from ten plasma samples with high 
performance liquid chromatography.  
Regions of interest were manually drawn, covering the putamen and the caudate nuclei and on the 
occipital and frontal cortex using Imadeus software (version 1.10, Forima Inc, Turku, Finland) on 
four consequent MRI planes realigned according to the PET images and further used for the 
calculation of the tissue activity curve from a dynamic [18F]FDOPA image. The influx constant 
(Ki, ml/gxmin) of [18F]FDOPA was calculated by applying the graphical analysis method by Patlak
et al. and Gjedde (Gjedde 1982, Patlak et al. 1983), using the metabolite corrected arterial plasma 
input and the occipital area as the reference region (best-fit in 15-60 minutes). The Mann-Whitney 
test was used for comparisons of the regional ROI-based 18F]FDOPA influx values between 
subjects with AS and controls. 
An additional confirmatory voxel-based statistical analysis was performed using Statistical 
Parametric Mapping version 99 (Friston et al.1995) and Matlab 6.5 for Windows (Math Works, 
Natick, MA). An analysis was made using small-volume correction on the striatal area and on the 
frontal cortex. For this analysis, parametric images in which each voxel indicates the Ki value of 
[18F]FDOPA were calculated using the same mathematical model as in the ROI analysis. The 
spatial normalisation of Ki images was performed using summed images and a PET template 
(Rakshi et al. 1999). A Gaussian kernel of 12 mm was used to smooth the normalised Ki images. A 
between-groups comparison was performed using T-contrasts and a multiple comparison corrected 
p-value of below 0.05 was considered significant.  
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9.4 GENETICS (V) 
9.4.1 LABORATORY STUDIES 
Genomic DNA was extracted from EDTA blood using standard procedures. The genome-wide map 
of microsatellite markers was based on Weber screening set 6 (Sheffield et al. 1995). Markers                 
for denser maps and replacement markers for the set markers that did not work satisfactorily                
were selected from the Marshfield Medical Research Foundation map 
(hhttp://research.marshfieldclinic.org/genetics). The primer sequences were taken from The 
Genome Database (www.gdb.org). The physical map and the most probable cytogenetic locations 
of the markers were taken from the UCSC Human Genome Browser (http://genome.ucsc.edu/; June 
2002 assembly) (Kent et al. 2002). In all, 415 microsatellite markers including 23 X-chromosomal 
markers were analysed in the primary screen. The marker map included a dense set of 
microsatellites on autism candidate regions on chromosomes 1q21-22 (Auranen et al. 2002), 2q31-
32 (Buxbaum et al. 2001, IMGSAC 2001a), 3q25-27 (Auranen et al. 2002), 6q16 (Philippe et al. 
1999), 7q (IMGSAC 1998, Buxbaum et al. 2001, IMGSAC 2001b, Liu et al. 2001, Auranen et al. 
2002, (CLSA 1999), 13q12-22 (CLSA 1999) and 16p13 (IMGSAC 2001a, Liu et al. 2001). Nine 
chromosomal loci were precision mapped in the second stage with 54 markers, which yielded an 
average intermarker distance of 3.2 cM in these regions.  
PCR reactions were performed in 15 µl reaction volume in 96 well plates. The reactions contained 
20 ng of genomic DNA, 6 pmol of both primers, 3 nmol of each nucleotide, 1.5-3.0 mM MgCl2, 10 
mM Tris-HCl, 50 mM KCl, 0.1% Triton X-100 and 0.23 U Dynazyme polymerase enzyme 
(Finnzymes, Espoo, Finland). The forward primers were labelled at the 5’ end with 6-FAM, TET 
or HEX fluorescent dye. The reactions were prepared with a Biomek 2000 pipetting robot 
(Beckman Instruments Inc., Fullerton, CA, USA) and performed with a thermal cycler (MJ 
Research, Cambridge, MA, USA). A hot-start procedure was used, i.e. the polymerase enzyme was 
added after the first denaturation step of 5 min at 95°C. The DNA amplification was carried out in 
30–35 cycles as follows: 1) denaturation step of 30 s at 94°C, 2) annealing step of 30 s at a 
temperature specific to each primer (48-62°C) and 3) elongation step of 30 s at 72°C. An 
elongation step of 5–15 min at 72°C terminated the reaction after final annealing.  
PCR products were pooled and electrophoresed on an ABI 377 DNA sequencer (Applera 
Corporation, Norwalk, CT, USA). Data were extracted from the gels using GENESCAN 3.1 
software (Applera Corporation, Norwalk, CT, USA). The genotypes were assigned automatically 
using the GENOTYPER 2.0 program (Applera Corporation, Norwalk, CT, USA) and verified 
manually by two independent individuals. Genotype errors were checked using the PEDCHECK 
1.1 (O'Connell et al. 1998) and SIMWALK 2.81 (Sobel and Lange1996) computer programs.  
9.4.2 STATISTICAL ANALYSES 
The MLINK program of the LINKAGE package (Lathrop and Lalouel 1984, Lathrop and Lalouel 
1986) was used for the two-point analyses. Both dominant and recessive analyses were performed 
with almost complete penetrance and a low phenocopy rate (dominant model, 0.001, 0.999, 0.999; 
recessive model 0.001, 0.001, 0.999). We thus emphasised the detection of linkage, which 
inevitably leads to a higher risk of type I errors (false-positives) (Hodge et al. 1997). Tests for 
heterogeneity and calculations of the proportion of linked families (α) were carried out using the 
HOMOG 3.35 program (Ott 1999). The ANALYZE program was used to conduct these analyses 
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(Terwilliger and Goring 1995). The allele frequencies for each marker were derived by the 
DOWNFREQ 2.1 program from the genotypes of all individuals who were genotyped in the study 
(Terwilliger 1995). An affected-only approach was adopted in all the analyses; in other words, the 
individuals were coded either as affected or as unknown. 
The multipoint analyses were generated using the NPL option of the GENEHUNTER program 
(version 2.1_r3beta), which should be particularly suitable for a dominant inheritance model 
(Kruglyak et al. 1996). The marker ordering and the genetic distances were taken from the 
Marshfield Medical Research Foundation map. When the markers were at the same position 
according to the genetic map, the UCSC Human Genome Browser was used to order the markers. 
When the physical map was used, equivalence between 1 cM and 1 Mb was assumed.  
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10. RESULTS 
10.1 CLINICAL FINDINGS (I) 
The prevalence of aberrant sensibility was significantly higher (OR, Mantel-Haentzel 38.27 (95% 
CI 6.29-232.77) in the individuals with AS than in their non-AS family members (Table 14).  
Among the subcomponents of altered sensitivity, hypersensibility to light, sounds, touch and smell 
emerged as being significantly altered in the group of family members with AS. In addition, 
prosopagnosia emerged as being clearly over-represented in family members with AS (Table 14, 
Table 15) (I, Table 3, Table 4), as the percentage of occurrence was 46.6% compared with 10.7% 
in the family members without AS. The latter figure is most probably also clearly elevated, 
although the prevalence of prosopagnosia in an average population is not known. Other features 
which were significantly more frequent in family members who fulfilled the criteria for AS were 
sleeping disturbances, aberrant eating habits and selection difficulties (Table 14, Table 15) (I, 
Table 3, Table 4). 
The results of the random effect models are presented in Table 14 (I, Table 3). They further 
confirm that altered sensibility (OR 14.0), prosopagnosia (OR 10.6) and special diet (OR 8.94) are 
highly typical of AS. Difficulty selecting (OR 4.31) and risk of sleep problems (OR 2.83) are also 
slightly higher in persons with AS than in controls.  
Table 14. Mantel-Haentzel (MH) pooled risk estimates (risk of the symptom in Asperger 
individuals)
 Overall 
prevalence  
% (n) 
Prevalence 
in controls 
% (n) 
Prevalence 
in cases 
% (n) 
ORMH (95% CI) 
Altered sensibility 69.3 (79) 46.4 (26) 91.4 (53) 38.27 (6.29-232.77) 
Prosopagnosia 28.9 (33) 10.7 (6) 46.6 (27) 20.46 (4.51-92.88) 
Special diet 37.7 (43) 14.3 (8) 60.3 (35) 8.41 (2.80-25.27) 
Difficulty selecting 36.8 (42) 19.6 (11) 53.4 (31) 4.46 (1.77-11.24) 
Sleeping disturbances 36.0 (41)  23.2 (13) 48.3 (28) 3.11 (1.24-7.78) 
Young appearance 42.1 (48) 30.4 (17) 53.4 (31) 1.92 (0.80-4.65) 
     
Hypersensibility to touch 31.6 (36) 8.9 (5) 53.4 (31) 12.16 (3.37-43.97) 
Hypersensibility to light 25.4 (29) 7.1 (4) 43.1 (25) 7.57 (2.13-26.87) 
Hypersensibility to sounds 33.3 (38) 16.1 (9) 50.0 (29) 5.59 (2.08-15.01) 
Hypersensibility to smell 34.2 (39) 23.2 (13) 44.8 (26) 2.56 (1.01-6.47) 
Hypersensibility to pain 11.4 (13) 7.1 (4)  15.5 (9) 2.54 (0.65-9.96) 
OR  = Odds Ratio 
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Table 15. Logistic regression models (risk of the symptom in Asperger individuals) 
 B SE p 
Altered sensibility  2.70 0.58 <0.001 
Prosopagnosia 2.26 0.56 <0.001 
Special diet 2.24 0.48 <0.001 
Difficulty selecting 1.57 0.42 <0.001 
Sleeping disturbance 1.11 0.41 0.007 
Young appearance  0.79 0.39 0.045 
    
Hypersensibility to touch 2.42 0.54 <0.001 
Hypersensibility to light  2.03 0.56 <0.001 
Hypersensibility to sounds  1.61 0.44 <0.001 
Hypersensibility to smell 1.00 0.42 0.017 
B = Model coefficient/parameter estimate 
SE = standard error 
p-value
10.2 NEUROIMAGING FINDINGS  
10.2.1 MRI study (II) 
Visual analysis 
Mild inconsistent alterations were detected in 13/28 of the individuals with AS compared with 6/23 
of the comparable controls. In six children or adolescents (II, Table 1) and in seven adults, there 
were mild structural alterations (II, Table 2) (p<0.13). 
Measurements 
The mean anterior-posterior diameter measured from an axial plane image of the mesencephalon 
was significantly smaller in the entire group of Asperger individuals (p<0.05, Mann-Whitney U) as 
compared to the controls. In the group of children, this same diameter (p<0.05, Mann-Whitney U) 
and also the anterior-posterior diameter measured from a midsagittal image (p<0.05, Mann-
Whitney U) of the mesencephalon were significantly smaller than in the age-matched controls (II, 
Table 3). 
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10.2.2 PET STUDIES 
ToM–PET study (III) 
Differences in rCBF during ToM- and Phys-stories in AS individuals 
Activation during ToM-stories 
There was activation during the ToM-test stories in the occipitotemporal and pericentral area 
bilaterally, the right temporal lobe, the medial frontal area predominantly on the right and in the 
thalamus (left) and the midbrain (right)(uncorrected p-value < 0.05) (III, Table 1). However, using 
strict statistical analysis the activation pattern did not differ significantly between the two types of 
stories in persons with AS.
Activation during ToM- stories – analysis using the small-volume correction
No clusters were found using the correction for multiple comparisons in the small-volume 
correction analysis. Two clusters with activation during the ToM-stories were found in the right 
medial frontal area with cluster sizes of 176 (uncorrected p-value 0.039) and 155 (uncorrected p-
value 0.05). 
Deactivation during ToM-stories
Analysis using the more liberal statistics identified several deactivated clusters, in the frontal cortex 
and temporal lobe bilaterally, in the left parietal lobe and in the right cerebellum (III, Table 1). 
There were no deactivations using the strict statistical analysis.  
Differences in rCBF during ToM- and Phys-stories in healthy controls
Activation during ToM stories Activation appeared in the medial frontal area on the left and on the 
right, the anterior cingulate gyrus, the right superior temporal gyrus and the occipitotemporal area 
bilaterally. The posterior cingulate gyrus, the thalamus, the striatum, the midbrain and pons were 
activated on the left (III, Table 2). There were, however, no significant activations using strict 
statistical analysis.  
Activation during ToM-stories -  – analysis using the small-volume correction
Using the frontal VOI, one large cluster covering the left and the right medial frontal area and the 
anterior cingulate gyrus was activated (cluster size 539, corrected p-value of 0.013).   
Deactivation during ToM  stories
There was deactivation in the precentral area and occipital lobe bilaterally, left posterior cingulate 
gyrus, right temporal lobe and the right cerebellum, but using strict statistics the deactivations 
remained insignificant (III, Table 2).  
Task by group interaction analysis.
No significant cerebral clusters were found.  
Group comparisons.
The AS group displayed increased activation in both the right and left cerebellum as compared to 
the control group when comparing the averaged images of all the images and when comparing the 
averaged images over the ToM-task images and the averaged images over the Phys-task images. 
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The control group displayed increased activation in the right frontal cortex, the left cingulate gyrus, 
the right parietal and the right temporal cortex (p<0.05). 
Dopamine–PET study (IV) 
As shown in Table 1 (IV, Table 1), the subjects with AS had higher [18F]FDOPA influx values in 
both the striatum and the frontal cortex, with the absence of an asymmetrical uptake. The SPM 
analysis confirmed this finding for the striatum, but it also disclosed large clusters located in the 
medial frontal cortex, the anterior cingulum, the left inferior frontal gyrus and the right superior 
frontal gyrus. They revealed an increase in Ki for [18F]FDOPA in the subjects with AS in 
comparison to the controls (V, Figure 1). 
10.3 GENETIC STUDY
The genealogical studies of all 17 study families stretched back to the 18th century. No common 
ancestors or geographical enrichment of the families were identified. The birthplaces of the 
ancestors were evenly distributed throughout the country. It is noteworthy that no shared ancestors 
were identified between the current Asperger families and the families included in the Finnish 
autism genome scan (Auranen et al. 2002).  
Stage I: Initial genome screen  
In the initial genome screen, 13 Asperger families (V, Table 1) were analysed using 415 
microsatellite markers. A total of 13 markers exceeded a two-point LOD score of 1.5 in the 
primary screen (V, Table 2). The highest two-point LOD scores were observed on 1q21-22, on 
chromosome 3p14-24 and on chromosome 4, 6q16, together with some nominal evidence of 
linkage at end of the chromosome 7q.  
Stage II: Fine mapping  
The loci with Zmax > 1.5 were analysed with more markers in the study sample of 17 families (V, 
Figure 1; Table 1). A total of 54 markers were analysed on 1q21-22, 3p14-24, 3q25-27, 4p14, 
4q32, 6p25, 6q16, 13q31-33 and 18p11.
Chromosome 1q21-22
A total of 20 microsatellite markers were genotyped covering a 19.7 cM region on 1q21-22. The 
best evidence of linkage was obtained with D1S484 using narrow diagnostic classification and 
dominant model (Zmax dom = 3.58). In addition, D1S2721 (Zmax dom = 2.88) and APOA2 (Zmax dom = 
2.75), locating 8.6 cM and 1.2 cM from D1S484, exceeded the two-point LOD score of 2.0 with 
narrow diagnostic classification. Several additional markers on this 17 cM region produced 
positive linkage values (V, Table 3). Significantly weaker evidence of linkage was systematically 
observed using a recessive model, based as expected on the inheritance of the phenotype in the 
families. Only D1S2721 (Zmax rec = 1.00, LC2) and D1S484 (Zmax rec = 1.11, LC1) exceeded Zmax rec 
values of 1.0. The highest multipoint NPLall score on 1q21-22 was 1.33 (p=0.044, LC1).  
Chromosome 3p14-24
Eight markers were genotyped on the 31 cM region on 3p14-24. The best evidence of linkage was 
observed at D3S2432 (Zmax dom = 2.50) with narrow diagnostic classification. In addition, D3S3547 
 58 
(Zmax dom = 1.10), D3S3685 (Zmax dom = 1.54) and D3S1766 (Zmax dom = 1.44) produced a two-point 
LOD score exceeding 1.0 using narrow diagnostic classification (V, Table 3). Again, the recessive 
model resulted in Zmax rec < 1.0 for all the markers. The maximum multipoint NPLall score of 3.32 
(p=0.0029) was observed at D3S2432 with narrow diagnostic classification.   
Chromosome 13q31-33 
Six markers were genotyped on the 21 cM region on 13q31-33. The highest two-point LOD scores 
were observed using the dominant model for D13S793 (Zmax dom = 1.59, LC2) and D13S1271 (Zmax 
dom = 1.16, LC1) located 3 cM apart (V, Table 3). The recessive model did not produce any 
evidence of linkage at this locus. Multipoint analysis using all fine mapping markers resulted in the 
highest NPLall score of 2.86 (p=0.0025, LC1) near D13S793 and D13S1271.  
Other chromosomes
The initial evidence of linkage on 3q25-27 at D3S2398 decreased to Zmax rec of 1.42 (LC1) in the 
second stage. None of the five flanking markers spanning a total length of 19 cM exceeded the 
LOD score of 1.0. The two regions of interest on chromosome 4 yielded only nominal evidence of 
linkage in stage II. Two markers on 4p14 with a mutual distance of 3.5 cM exceeded the Zmax of 
1.0 in the two-point analyses (D4S2408, Zmax rec = 1.04, LC2; D4S3001, Zmax rec = 1.06, LC2). 
D4S2368 located on 4q32 resulted in a Zmax dom of 2.82 with narrow diagnostic classification. 
However, none of the nearby markers on 9.9 cM region exceeded a two-point LOD score of 1.0. 
The multipoint analysis on this locus resulted in an NPLall score of 1.48 (p=0.050, LC1). On 6q16, 
three markers exceeded the Zmax of 1.0 (D6S1056, Zmax dom = 1.19, LC2; D6S1671, Zmax dom = 1.07, 
LC2; D6S1021, Zmax dom = 1.33, LC1), but all the multipoint analyses resulted in Zmax < 1.0. 
Finally, the putative linkage signals at D6S1668 (Zmax rec = 0.85, LC1) and D18S59 (Zmax rec = 0.98, 
LC1) disappeared in the second stage.  
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11. DISCUSSION  
11.1 METHODOLOGICAL CONSIDERATIONS
The diagnostic procedures were based on the official diagnostic criteria for autistic disorders used 
in the ICD-10 (WHO 1993) and DSM-IV (APA 1994) manuals. These apparently represent 
experts' generally accepted views of the clinical delineation of AS at the time at which the latest 
revisions of these instruments were made. One evident drawback of these current sets of diagnostic 
criteria is that the distribution of features or personality traits underlying the sets of criteria in an 
average population is not known. The same drawback is also characteristic of many of the 
screening questionnaires used in the diagnostic process. The question of whether the sets of criteria 
used routinely truly represent the core features of AS is perhaps justified. 
As seen on the graph (Table 12), the subsets of individuals and families recruited for the present set 
of studies which make up the present thesis were derived from the same original series. Our series 
is not a population-based one, as the families that are included were originally recruited from 
clinics to which the index case had been referred for a diagnostic evaluation. Another potential 
reason why the families which were chosen for our studies did not necessarily completely reflect 
the average AS population is that, for analytical reasons, we focused on large pedigrees with 
several AS individuals. This may have led to a preponderance of individuals and families with 
pronounced symptoms and signs. In order to be able to compare the findings obtained in clinical, 
neurophysiological, neuropsychological, neuroimaging and molecular genetic studies, we chose the 
participants in the separate studies (I-V) so that the overlap was maximised. A complete overlap 
was not possible, due to the different sizes and age distribution of the separate studies. The best 
overlap can be found in the two PET studies (III-IV) (Table 12). One-third of the subjects in the 
PET studies were also involved in the MRI study (II). The control group was the same in both PET 
studies, whereas the control material in the MRI study was derived from the healthy control 
reference series collected at the Department of Radiology, Helsinki University Central Hospital. 
This means that the results of the neuroimaging studies were reasonably comparable. In the two 
largest studies of clinical issues (I) and molecular genetics (V), the overlap is 72/119 (60%), which 
appears to be of importance, as the clinical AS-related features appear to be at least partly 
genetically determined. 
11.1.1 CLINICAL STUDY (I) 
The families analysed in this study (I) were drawn from the original series of 29 families, so that 
large families comprising at least two generations and also consisting of individuals without AS 
were included. This was necessary for the analyses involved, but this subsample may represent an 
enrichment of AS traits. As a highly detailed evaluation of the fulfilment of the current ICD-10 
(WHO 1993) and DSM-IV (APA 1994) criteria was carried out, the clinical presentation of these 
family members appears to have been recorded in sufficient detail. 
The new aspect in this analysis was the evaluation of a number of features known to occur in AS, 
which are not included in the official diagnostic criteria. The presence of these features was in 
principle on the basis of a structured interview which was used uniformly for all the family 
members who were studied. To the best of our knowledge, this issue has not previously been 
studied and not in a comparable setting. As a result, no generally accepted diagnostic instrument 
was available. The drawback of the interview instrument developed for the present study was the 
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lack of validation on the basis of an average population. This problem was considered to have been
eliminated at least in part by only administering the questionnaire to the families in this particular 
study in order to elucidate the presence of the listed additional features. By using non-AS 
individuals from the same families as a comparison group in the assessment of clinical signs, we 
also attempted at least in part to control for the effects of the family social environment. Another 
drawback was that, as the ascertainment of these new features was based on a consensus, no 
validation of this instrument was carried out.  
11.1.2 NEUROIMAGING STUDIES (II-IV) 
MRI study (II)
The AS subjects in the neuroimaging studies were recruited from two units; the Helsinki University 
Central Hospital and the Helsinki Asperger Center, Medical Center Dextra. The patients were 
recruited to the study in the order they were referred for diagnostic evaluation, excluding only 
those with any accompanying neuropsychiatric disorder and/or psychiatric medication. As a result, 
this AS sample can be expected to be representative of individuals seeking or referred for a 
diagnostic evaluation. The control group in the MRI and PET studies was carefully evaluated for 
any neuropsychiatric disorders and no control had or had had any such disorder. The quality of the 
controls was further enhanced by also interviewing all of them using the ASSQ (Ehlers et al. 1999) 
and the ASDI (Gillberg et al 2001). As a result, Asperger traits should not have been represented in 
the controls.
One strength of the MRI study (III) was that the visual analysis was carried out by two raters 
irrespective of each other. The neuroradiologist (TA), one of the raters in the MRI, is a member of 
a research team which developed a method of measuring the size of the brain stem using routine 
MRI by measuring the sagittal midline diameters of the mesencephalon, pons and medulla 
oblongata (Raininko et al. 1994). This method was used in our MRI study and has previously been 
shown to be highly reliable, with an inter-rater reliability of 0.91 (Raininko et al. 1994). Also 
measuring the specific anatomical structures of the mesencephalon (tectum, tegmentum and basis 
peduncle) would have been an advantage, but the resolution was not compatible with a reliable 
analysis of these very small areas. The small means would therefore have made the detection of 
differences difficult. A 3D analysis would have increased the reliability of the results and also 
made assessments of brain asymmetry possible, but at the time of this study the technical facilities 
for this were not available. 
Theory of Mind-PET study (III)
One essential methodological feature of the Theory of Mind-PET study (III), by which it differed 
from most other studies, was the use of strict statistics. On the basis of the experience acquired in 
the present study, the kind of statistical analysis that is used is basically arbitrary, as this can 
evidently markedly influence both the results and the discussion based on them. This is an 
important issue and it is not unlikely that at least part of the variability in the neuroimaging results 
in AS and related neuropsychiatric disorders is due to inconsistently applied statistics.  
One weakness of our Theory of Mind-PET study (III) was the lack of a baseline condition, during 
which brain activation without any stimulus (auditory or visual) could have been recorded. In 
previous studies, the baseline issue has not been resolved in a uniform manner. Adding a baseline 
recording would have expanded the already somewhat extensive trial and might therefore have 
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increased the variability of the results. In the discussion of the results, the restrictions caused by the 
lack of a baseline were taken into account. This potential source of error was therefore essentially 
eliminated.  
FDOPA-PET study (IV) 
One potential methodological problem in the FDOPA-PET study (IV) was caused by the fact that 
only four of the total of eight AS subjects, but all the controls, received a 150 mg dose of carbidopa 
before the recording. Carbidopa blocks the peripheral decarboxylation of [18F]FDOPA and 
enhances the quality of the images but has no impact on the Ki values using the analysis method in 
question. Analysis of the clusters confirmed this, as the groups did not differ from each other. 
11.1.3 MOLECULAR GENETIC STUDY (V) 
The sample of large two- to three-generation families in our study was expected to increase the 
chance of finding susceptibility genes for AS. The Finnish population, which originated from a 
limited number of founders and was also subsequently fairly isolated, with an increase in genetic 
homogeneity, has been considered to be advantageous in genetic studies of complex disorders 
(Ekelund et al. 2000). Population registries stretching back to the 16th century allowed us to trace 
common ancestors and the construction of mega families in order to maximise the genetic and 
environmental homogeneity. Furthermore, the homogeneous cultural background made it easier to 
analyse the relationships between genes and environment, once the susceptibility genes had been 
isolated.
The molecular genetic analyses were carried out at the Department of Molecular Genetics, 
University of Helsinki, Helsinki, Finland, which has a long and impressive record of identifying 
susceptibility genes for various types of disorder. All the background expertise at this department 
was available, whenever applicable, for the laboratory analyses in the present study. Another 
advantage was that the same research group was responsible for the analyses throughout the 
procedure. 
11.2 THE DIAGNOSTIC CRITERIA FOR THE CLINICAL ENTITY OF ASPERGER  
SYNDROME – NEED FOR REVISION? 
AS has a short history of being officially acknowledged as representing a separate clinical entity, as 
it was incorporated in the ICD-10 in 1993 (WHO 1993) and in the DSM-IV in 1994 (APA 1994). 
The present study appears to show that the present set of inclusion criteria does not satisfactorily 
reflect the clinical findings, as there are indisputably several symptoms or signs associated with AS 
which are not included in the ICD-10 (WHO 1993) or DSM-IV (APA 1994). Our findings that 
some clinical features, such as prosopagnosia, are apparently more common in non-AS family 
members than in the average population speaks in favour of the fact that the mere presence of one 
or more unusual biological features does not as such cause the syndrome.  
The changes in the clinical features that apparently take place over time in AS have so far been 
outlined in an extremely unsatisfactory manner, as most studies focusing on the clinical issues have 
dealt with children and adolescents. The observation of Nylander and co-workers (2001) that 3.2% 
of the adults with various psychiatric diagnoses in retrospect in their childhood would have 
fulfilled the diagnostic criteria for AS highlights the fact that the clinical appearance of AS is all 
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but stable over time. It is evident that the variability in the clinical findings need to be 
systematically studied in a large clinically-based population series which also represents adult age 
groups. If possible, the change over time should also be reflected in the inclusion criteria. 
11.2.1 ROLE OF CLINICAL SYMPTOMS AND SIGNS NOT INCLUDED IN THE ICD-10 
           AND  DSM-IV 
Sensory integration problems 
There is no epidemiological data relating to sensory integration problems in the average 
population. The detailed nature and severity of sensory integration problems have not previously 
been studied in AS. On a general level, our observations of a change in sensory integration in the 
AS group are well in line with the results of corresponding studies on autism. Altered sensibility 
has been reported in 42–88% of older children with autism (Gillberg and Billstedt 2000 and 
Baranek 2002). According to Baranek (2002), hypo/hyper reactions in auditory processing occur in 
autism in up to 100% of cases. This is in good agreement with our finding of auditory hypo/hyper 
sensibility being almost as common in AS. 
The nature of aberrant auditory sensory processing in AS and autism still remains open. The study 
by Jansson-Verkasalo and co-workers (2002) indicates that auditory sensory processing is deficient 
in children with AS. On the other hand, Čeponienė and co-workers (2003), when studying high-
functioning verbal children with autism using MMN (mismatch-negativity), demonstrated that, 
first, auditory orienting deficits in autism cannot be explained by sensory deficits and, second, that 
orienting deficits in autism might be speech–sound specific. Auditory processing impairments in 
AS and autism deserve special attention, as they may constitute a part of the pathogenesis of the 
behavioural problems. Despite the fact that abnormal sensory responses in autism are regarded by 
many scientists as ‘primary’, they are not included in the official diagnostic criteria (Gillberg and 
Billstedt 2000). 
Prosopagnosia 
The present study (I) revealed that 46.6% of the individuals with AS had face blindness compared 
with 10.7% of the non AS-individuals in the same families. This finding is difficult to judge, as the 
prevalence of prosopagnosia in the general population is not known, but the phenomenon is most 
probably far more rare than among the non-AS members of the AS families in our study (I). On the 
basis of another subgroup of AS families derived from the original series of 29 families, Kulomäki 
and co-workers (2003) showed that 23/71 adults and 9/39 children had pure prosopagnosia without 
any other impairment in visual recognition, whereas the rest of the AS individuals displayed 
prosopagnosia in combination with the impaired visual recollection of pictures (Kulomäki et al. 
2003). This finding speaks in favour of the fact that pure prosopagnosia is indeed a characteristic 
finding in a subgroup of AS. However, it has also been suggested in previous studies that 
prosopagnosia is an essential symptom in AS (Davies et al. 1994, Kracke 1994, Pietz et al. 2003). 
Kracke (1994) hypothesised that low empathy, a form of AS, is a consequence of prosopagnosia 
from infancy, which he presumed to be of cerebral origin. It appears that persons with AS process 
faces as if they were objects and appear to rely more on identifying individual pieces of the face 
rather than on the overall configuration (Davies et al. 1994, Klin et al. 2000, Schultz et al. 2000a, 
Schultz et al. 2000b). Since the recognition of faces is an important part of interpersonal interaction 
and a prerequisite for successful functioning within a social group, the result of our study lends 
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further support to the theory that prosopagnosia contributes to impaired social communication in 
persons with AS. 
Sleeping problems 
In our study (I), the occurrence of reported sleeping problems in AS and non-AS members of the 
AS families did differ. This result is in agreement with several other studies. Paavonen and co-
workers (2004) studied a sample of 68 children with AS (age 6-17 years) with sleeping problems, 
representing the same 29 families from the original series. All the children had sleeping problems 
every night or almost every night. Two questionnaires (one to be completed by the children 
themselves and the other by the parent) were used to evaluate the severity of the sleeping problems; 
the Children’s Self Report Form for the sleeping problems (Owens et al. 2000) and the Sleep 
Disturbances Scale for Children (Bruni et al. 1996). This approach identified 15 subjects (13 boys, 
2 girls) with severe sleeping problems. They were selected for melatonin treatment, which was 
monitored by achigraphy and by the Children’s Behaviour Check List for parents (Achenbach 
1991). A teacher’s questionnaire was used to evaluate the children's performance at school (Owens 
et al. 2000). There was a significant improvement in sleeping patterns and the sleep latency 
decreased in all the children who used melatonin. In a community-based study by Neveus and co-
workers (2001) (1,413 children, age 6.2-10.9 years; mean 7.9 years), 13% had insomnia, 7% 
sleepwalking and 4% had daytime sleepiness and, in overall terms, epidemiological studies have 
shown that approximately one-third of all children suffer from sleeping problems. This means that 
sleeping problems are less severe in healthy children than in children with AS.  
Tani and co-workers (2003) studied 20 adults (14 males and 6 females; age (27.2+7.3)) who also 
represented the same series of 29 Finnish families and compared them with 20 age- and gender-
matched controls. The sleep questionnaire revealed insomnia in 90%, while the sleep diary 
revealed it in 75% of the adults with AS. The findings of the pioneering first polysomnographic 
study of AS by Godbout and co-workers (2000) were also in line with this. They compared eight 
AS subjects (7 male, one female; age range 7-53 years; 22.6+13.6 years) with age- and gender-
matched controls and showed that the persons with AS had sleeping disorders and defective sleep 
control.
The variability of results even within the same series when it came to sleep may be due to the fact 
that the interview method used in the present study (I) was neither very specific nor very accurate 
with respect to describing sleeping problems. In this respect, there is a major difference compared 
with the methods used in the studies by Godbout (2000), Paavonen and co-workers (2004), Tani 
and co-workers (2003) and Tani and co-workers (2004). Another potential explanation is that the 
sleeping problem is a more general subjective complaint in families with AS. The observation by 
Tani and co-workers (2003) that adults with AS suffer from subjective, but not objective, sleeping 
difficulties partly offers some explanation for this result. From a clinical point of view, sleep 
disturbances are typical among people with AS and should be taken into account when a person is 
referred for a diagnosis, especially when the problem can be helped with melatonin, for example  
(Paavonen et al. 2003, Paavonen 2004).  
Eating problems 
The results of the questionnaire included in the clinical study (I) revealed that as many as 60% of 
the AS individuals considered themselves to have aberrant eating habits (such as unusual/odd food 
preferences, unusual routines regarding arranging food on the plate and eating, presence of 
aversion due to the smell of the food, ongoing or past anorectic behaviour). Eating problems 
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(Hebebrandt et al. 1997, Sobanski et al. 1999) and also anorexia nervosa have been reported to be 
over-represented in AS (Råstam et al. 1997, Ahearn et al. 2001, Gillberg and Billstedt 2000). In 
this respect, our study supports earlier findings, but it also shows that aberrant eating habits are 
clearly a phenomenon associated with the diagnosis and not with the family.  
In the eating problems, it is possible to identify features of AS, OCD and anorexia nervosa. The 
confusion of concepts is increased by the fact that the criteria for OCD and anorexia nervosa 
overlap (Tantam 2000, Martin et al. 2000). On the other hand, there are studies which show that 
some anorexia nervosa patients fulfil the criteria for OCD (Matsunaga et al. 1999, Råstam et al. 
2000). Obsessional traits and symptoms are a prominent feature in anorexia nervosa, but it has 
been questioned whether OCD-like symptoms related to core anorexia nervosa pathology fully 
meet the criteria of OCD. Core symptoms of anorexia nervosa have been characterised as ego 
syntonic; those of OCD as ego dystonic (Matsunaga et al. 1999). The issue of whether core 
anorexic symptoms are a variant of OCD therefore remains controversial.  
Nevertheless, the effective treatment of feeding problems requires a direct, objective assessment to 
identify the precise nature of the problems. The current diagnostic criteria for AS and other PDD 
do not include aberrant eating. As it seems that aberrant eating habits are frequent in AS, adding 
them to the diagnostic manual of the ICD-10 and DSM-IV should be considered.  
The general result of the clinical study (I) speaks in favour of the fact that disturbed sensory 
integration is not confined to auditory function alone but may be a more extensive phenomenon in 
AS, as these individuals are frequently hypersensitive to noise, bright light, strong smells and 
touch. These over-reactions to sensory stimuli quite often have an invalidising effect on a person 
with AS. Our results appear to be fairly straightforward, as it seems that prosopagnosia, sensory 
integration problems, sleeping problems and special eating habits are associated with AS and may 
in the future be incorporated into the diagnostic criteria, thereby facilitating the diagnostic 
procedure. However, our results relating to the symptoms and signs that are not included in the 
ICD-10 or DSM-IV will probably not help in the differentiation of autism and AS, as it is obvious 
that similar features also exist in autism. On the other hand, it seems obvious that the presence of 
the abnormal processing of sensory information is a key feature of autism spectrum disorders. The 
impact of these traits on our understanding of these disorders may hitherto have been 
underestimated. The addition of these traits (prosopagnosia, aberrant sensory, sleeping and eating 
habits) to the ICD-10 could be considered as additional questions to support the diagnosis and our 
clinical findings should be taken into account when the next revisions of the ICD and DSM take 
place. 
11.3 NEUROIMAGING  
11.3.1 MRI STUDY (II)  
Despite the fact that cases and controls did not differ to any statistically-significant degree from 
each other in the visual analysis, the over-representation of minor structural abnormalities in the 
cases is still striking. This finding could be interpreted as indicating the early disturbance of brain 
development. This is of interest, as a feature of this kind appears to be well documented in infantile
autism (Shoumitro and Thompson 1998). 
The main finding in our study (II) that the midsagittal diameter of the mesencephalon was 
statistically-significantly reduced in AS is in agreement with the results of comparable studies of 
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some other neuropsychiatric conditions. In an MRI study of 29 children with autism (age range 
2.3-7.8 years; mean age, 4.3+1.6SD) with 15 controls matched for age and gender, Hashimoto and 
co-workers (1991) obtained a similar result. In addition, Hashimoto and co-workers (1993) 
demonstrated that the midsagittal area of the mesencephalon was reduced in HFA and, in a 
controlled MRI study of schizophrenia, Nopoulos and co-workers (2001) also reported a similar 
result.  
Despite the similarity of the results, care needs to be taken when drawing conclusions, as the 
above-mentioned MRI studies were not fully comparable with our study.  First, the MRI studies of 
autism and HFA by Hashimoto and co-workers (1991, 1993) were carried out more than a decade 
ago, when the MRI technique was not as advanced as it is today. Secondly, in two of the MRI 
studies, our study and the autism study by Hashimoto and co-workers (1991), the midsagittal 
diameter was measured, whereas the midsagittal area of the mesencephalon was measured in the 
MRI studies of schizophrenia (Nopoulos et al. 2001) and HFA (Hashimoto et al. 1993). Despite 
these methodological differences, we compared our study with those by Hashimoto and co-workers 
(1991, 1993) and Nopoulos and co-workers (2001) because they were the only MRI studies of the 
mesencephalon in neuropsychiatric disorders. As Hashimoto and co-workers (1991, 1993) used the 
best MRI techniques available at that time and adequate control material, we concluded that their 
studies were reliable enough for a comparison with our study. For the same reason, we considered 
the studies of schizophrenia (Nopoulos et al. 2001) and HFA (Hashimoto et al. 1993) to be 
comparable, despite the fact that they had measured the area of the mesencephalon. The overall 
conclusion was that MRI appears to produce similar findings in the mesencephalon in AS, autism, 
HFA and schizophrenia. 
The reduced mesencephalon measurements in different neuropsychiatric disorders indicates 
possible similarities in the brain anatomy and even in the underlying pathomechanism of AS, HFA, 
autism and schizophrenia. The mesencephalon represents the smallest and least differentiated 
segment of the brain stem and contains the perikarya of all the dopamine neurons in the human 
brain. The dopaminergic nucleus substantia nigra (SN), which is situated in the mesencephalon, is 
divided into two parts: the pars reticulate (SNr) and pars compacta (SNc) (Martin 1996, Nopoulos 
et al. 2001). The latter consists of neurons containing dopamine. Dopamine is an important transfer 
agent in the brain, modulating social behaviour, perception of the outside world, motor activity and 
attention skills (Ernst et al. 1997, Martin 1996). The dopaminergic fibres of the SNc synapse on 
neurons in the different parts of the brain, the prefrontal association area, limbic association cortex 
in the medial frontal lobe, cingulate gyrus and amygdala (Martin 1996), all of which are important 
for the development of ToM skills, which is regarded as the basic problem in AS (Fletcher et al. 
1995, Happe et al. 1996). The dopaminergic fibres of the SNc also synapse on neurons on the 
striatum through the nigrostriatal tract (Martin 1996), the striatum being the place where alterations 
in dopamine functioning in schizophrenia have been demonstrated (Hietala et al. 1995, Hietala et 
al. 1999).
The raphe nucleus, which is partly situated in the mesencephalon, is involved in regulating 
inhibition and anxiety, as well as mediating resilience and enabling a person to cope with ongoing 
and unavoidable stress and modulating appetite and sleeping rhythm. The serotonergic projections 
to the limbic system structures originate from the dorsal and median raphe nucleus (Martin 1996). 
The serotonergic system has been implicated in autism (Cook et al. 1997, Chugani et al. 1997, 
Chugani et al. 1999, Chugani 2002) and schizophrenia (Pearlson 2000), for example. The 
ascending serotonergic projections of the serotoninergic raphe nucleus synapse on neurons in the 
amygdala, hippocampus, cerebral cortex and striatum (Martin 1996, Ninan 1999). It is therefore 
not unlikely to assume that the substantia nigra and the raphe nucleus are somehow affected in 
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individuals with AS and that a dysfunction in these nuclei could be compatible with some of the 
core signs and symptoms of AS.  
Fig. 1. Dopamine connections. 
The connection from the cerebellum  
to the dopamine containing  
nucleus subtantia nigra (SNr) 
in the mesencephalon and the  
dopamine pathway to the striatum 
(nigrostriatal pathway) 
As corresponding structural abnormalities in the dopamine-dependent part of the midbrain have 
been detected in AS, autism, HFA and schizophrenia and, as dopamine abnormalities have been 
described in autism and schizophrenia, it is attractive to speculate that dopaminergic dysfunction 
may also be present in AS. This is naturally highly speculative and efforts should now be directed 
towards studying the activation of dopaminergic and serotonergic pathways during specific tests in 
AS individuals in order to determine whether any abnormality can be detected in the 
mesencephalon.  
11.3.2 THEORY OF MIND-PET STUDY (III)  
The overall increase in the activation of the cerebellum in the AS group (III) has not been reported 
previously using this neuroimaging method. As this activation was not specifically related to the 
test stories, this observation indicates that this type of cerebellar activation might be a general 
feature in AS. The observation of AS individuals activating the cerebellum more extensively than 
controls, regardless of the type of tasks, focuses attention on the fact that the cerebellum has 
functions and connections related to cognition and behaviour. There are connections from the 
cerebellum, for example, to the dorsolateral prefrontal cortex, the medial frontal cortex, the parietal 
and superior temporal areas, the cingulate cortex and the posterior hypothalamus (Reiman et al. 
1997).  These connections are involved in language, planning and reasoning (Nichols  and  Holmes 
Mesencephalon 
SNc 
Striatum
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2001). The cerebellum has traditionally been linked with motor control (Allen et al. 1997, Reiman 
et al. 1997, Andreasen et al. 1999), but recent studies have also linked the cerebellum to tasks that 
involve memory processing (Allen et al. 1997, Andreasen et al. 1999), working memory (Klinberg 
1997, Liu et al. 2000, Nichols and Holmes 2001), attention, verbal learning, complex problem-
solving (Allen et al. 1997), executive function, spatial cognition, language and the emotional 
regulation of behaviour (Gao et al. 1996, Allen et al. 1997, Reiman et al. 1997), acquisition and 
sensory discrimination (Gillberg and Gillberg 1989, Middleton and Strick) and memory for faces 
(Calarge  et al. 2003, Paller et al. 2003). Cerebellar activation during ToM-PET studies has also 
been reported in healthy individuals by Brunet and co-workers (2000), Castelli and co-workers 
(2002) and Calarge and co-workers (2003), thereby adding to the rapidly-expanding evidence that 
the cerebellum is an important cognitive anatomic brain area in the human brain.
An increase in the serotonin synthesis of the cerebellum was reported in the PET study by Chugani 
and co-workers (1997) in autism. Against this background, it is interesting that the frontal cortex 
has its projections to the cerebellum (dentate nucleus), which projects back to the frontal cortex via 
the thalamus. According to the authors, a change in the serotonergic neuromodulation of 
dentothalamocortical synaptic activity could be one of the pathophysiological mechanisms 
underlying dysfunction in autism (Chugani et al. 1997) 
The medial frontal cortex appears to be a crucial region for ToM tasks. Like previous PET studies, 
which were all quite different in their designs and stimulus materials, our study (III) showed that 
the medial prefrontal region is activated in persons with AS and healthy controls when human 
beings attribute mental states. The function of this region is thought to be the maintenance of a 
representation of the mental state of self (Frith and Frith 1999). The previous ToM-PET studies 
that also found medial frontal activation were all quite different in their designs and stimulus 
material (Table 16). In spite of this, the different designs found medial frontal activation,
predominantly in the left hemisphere, during the ToM condition, which was also the activation 
pattern in our study. We therefore conclude that this region must be centrally involved in the core 
process of mentalising in a manner that is independent of the modality through which the ToM task 
is presented (e.g. visual vs. verbal).  
When comparing the results of our studies with previous ones, the comparability of incongruent 
reporting of anatomical areas hampers studies. In order to overcome this difficulty, we expressed 
all such available data in terms of Brodmann’s areas (Table 16).  
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11.3.3 FDOPA-PET STUDY  
Our study (IV) provided evidence of an increase in the activity of the presynaptic dopamine system 
in AS. This result should be interpreted with care, as this increase in [18F]FDOPA influx does not 
specify the underlying mechanism. As a result, there may be an elevated number of dopamine 
nerve terminals or increased presynaptic dopamine synthesis capacity or both.  
As an increase in [18F]FDOPA uptake in the striatum with an absence of asymmetrical uptake in 
the caudate nucleus has also been shown in schizophrenia (Hietala et al. 1995, Hietala et al. 1999, 
Lindstrom et al. 1999), it is attractive to speculate that dopaminergic dysfunction may play an 
essential role in the pathogenesis of these two neuropsychiatric disorders. On the other hand, the 
hyperactivity of the dopaminergic function may well be an unspecific finding, which is perhaps 
related to some of the symptoms rather than to the specific diagnosis. 
According to Moore and co-workers (1999), the prefrontal and temporal cortical abnormalities are 
important in the etiology of many of the symptoms of schizophrenia, including psychosis. 
However, the cortical systems that appear to have structural and/or metabolic abnormalities in 
schizophrenia patients potently regulate forebrain dopamine transmission through a number of 
mechanisms. In turn, dopamine modulates excitatory transmission mediated by frontal and 
temporal cortical projections to the basal ganglia and other regions. In schizophrenia, a dysfunction 
within limbic-related cortical structures results in the dysregulation of forebrain dopamine systems. 
The collective dysfunction of these systems leads to profound abnormalities in the function of 
cortico-basal ganglia-thalamic circuits and the behaviours mediated by these circuits (Moore et al. 
1999).
Although schizophrenia was first thought of as a dopaminergic disorder, evidence is amassing in 
support of a cortical disturbance in this disorder; one consequence of which is a disruption in the 
cortical regulation of subcortical dopamine systems (Grace 2000). The study by Grace (2000) 
shows that the hippocampus plays a major role in this interaction, in that, along with the dopamine 
system, it provides a gating influence over information flow from the prefrontal cortex at the level 
of the nucleus accumbens. The author therefore proposes that schizophrenia is a developmentally-
related disorder, in which the disruption of the hippocampal influence over the limbic system 
during ontogeny results in a pathological alteration of corticoaccumbens interactions in the adult 
organism (Grace 2000).  
Nopoulos and co-workers (2001) have suggested a neural circuit which leads to forebrain 
hyperactivity in schizophrenia. The proposed neural circuit is as follows: Purkinje cells of the 
cerebellar cortex exert an inhibitory action on the deep fastigial nucleus of the vermis, a part of the 
cerebellum. The output of this nucleus is excitatory and projects to the nuclei in the 
mesencephalon, which have dopaminergic projections to the mesolimbic regions. As a result, a 
lesion or malfunction of the cerebellar cortex would lead to the disinhibition of excitatory 
projections of the deep nucleus of the vermis to dopaminergic neurons in the mesencephalon, 
resulting in a hyperdopaminergic state (Nopoulos et al 2001).  
As dopamine function on the basis of our results (IV) appeared to be distorted in a way similar to 
that seen in schizophrenia, it is possible to speculate that dopamine-mediated functions of the 
studied areas might also display comparable aberrations.  
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Fig. 2. A schematic drawing of 
the suggested (Nopoulos et al. 2001) 
neural circuit  
connecting the frontal cortex  
to the cerebellum,  
mesencephalon and striatum.  
Our results differ from those of the FDOPA-PET study in autism by Ernst and co-workers (1997), 
who showed that the accumulation of [18F]FDOPA was reduced by 39% in the anterior medial 
prefrontal cortex, indicating low medial prefrontal dopaminergic activity. The two studies are not 
fully comparable in methodological terms as the study by Ernst and co-workers (1997) differs from 
our study as propofol, an anaesthetic drug, was used for sedation in 11 of 14 children. In animal 
studies, this compound has been shown to reduce dopamine release in the nucleus accumbens 
(Schulte et al. 2000), which is part of the basal ganglia. It has also been shown that propofol 
reduces relative regional cerebral blood flow (rCBF) in the frontal cortex (Kaisti et al. 2003). It is 
therefore impossible to judge whether the divergent results reflect neurobiological differences 
between the two disorders or simply methodological differences.  
When comparing our results with those obtained in ADHD using comparable PET techniques, no 
overlap was noted, as dopamine-increased accumulation in ADHD was only detected in the right 
midbrain (Ernst et al. 1999b). Our findings partly overlap the results obtained in Tourette 
syndrome, as an accumulation in the left caudatus has been shown in this syndrome (Ernst et al. 
1999a). On the other hand, it is notable that methodologically comparable PET studies reveal a 
similar right midbrain dopamine accumulation in ADHD and Tourette syndrome. Regardless of the 
fact that studies of dopamine in various neuropsychiatric disorders do not present entirely 
concordant results, they still speak in favour of the fact that dopamine is primarily or secondarily 
involved. The fact that there is hyperactivity in a different region in ADHD than in other 
neuropsychiatric disorders may still indicate that there is a distorted regulation of frontal cortical 
activity in this disorder as well. 
Furthermore, the defects in the dopamine system may also be related to a possible underlying 
disturbance in brain maturation, as dopamine plays a significant role in both the basic development 
and the further maturation of the brain (Lauder 1993).   
11.4 MOLECULAR GENETIC STUDY (V) 
In our AS study (V), in the fine mapping stage, the highest two-point LOD scores were observed 
on chromosomes 1q21-22, 3p14-24, and 13q31-33 and, in the second stage, on 3q25-27. The most 
striking finding was the overlap of the schizophrenia locus on chromosome 1 between AS in our 
Finnish series (V) and of schizophrenia in a Canadian study (Brzustowicz et al. 2000). Brzustowicz 
Frontal cortex 
Striatum 
Mesencephalon 
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and co-workers  (2000) reported a very high multipoint LOD score of 6.50 in 22 Canadian families 
with dominantly inherited schizophrenia, with a marker located only 1.2 cM from the best marker 
in our study. Gurling and co-workers (2001) performed genetic linkage analysis in 13 large 
multiply-affected families containing multiple affected cases in three or more generations, an 
absence of bipolar affective disorder and a single progenitor source of schizophrenia with unilineal 
transmission into the branch of the kindred sampled, thus reporting more evidence for linkage in 
schizophrenia locating around 10 cM from the best marker in our study. In the Finnish population, 
linkage for chromosome 1 was also found (Hovatta et al. 1998, Ekelund et al. 2000, Ekelund et al. 
2001) for schizophrenia, but these loci were located more than 50 cM telomerically from the best 
markers reported in our study. Interestingly, a multipoint LOD score of 2.63 was also found for this 
region in Finnish families with autism (Auranen et al. 2002).
Another overlapping locus for AS in our study (V) and schizophrenia is on 13q31-33. This locus 
has been reported to be a major predisposing locus for schizophrenia (Blouin et al. 1998, 
Brzustowicz et al. 1999, Badner and Gershon 2002) and bipolar disorders (Detera-Wadleigh et al. 
1999, Kelsoe et al. 2001, Badner and Gershon 2002), thus representing another overlapping locus 
for AS and neuropsychiatric disorders.  
The overlap of the Finnish autism series for chromosome 1 and 3 (Auranen et al. 2002, Auranen et 
al. 2003) with our AS series is also highly notable. The most significant evidence of linkage was 
observed for chromosome 3q25-27, in which an MLS of 4.81 was observed, assuming a dominant 
mode of inheritance (Auranen et al. 2002). The study performed by Auranen and co-workers 
(2002) is the only autism screen so far which has focused on an isolated population. In our study 
(V), there was modest evidence of linkage throughout the 3q25-27 region, implying that the 
identified AS loci overlap with susceptibility loci reported earlier for autism. In the nine 
previously-published, large-scale, genome-wide scans of autism spectrum disorders, evidence of 
linkage between autism and AS was obtained when a wide phenotype assigned both autism and AS 
as being affected by autism spectrum disorders  (IMSAG 1998, CLSA 1999, Philippe et al. 1999, 
Risch et al. 1999, Buxbaum 2001, IMSAG 2001b, Liu et al. 2001, Auranen et al. 2002,Shao et al. 
2002).
Viewed in a wider context also including the studies performed by other groups, our results (V) 
relatively clearly indicate a shared susceptibility gene region for Asperger syndrome, infantile 
autism and schizophrenia on chromosome 1. However, it has to be borne in mind that these results 
need to be replicated in an independent, and hopefully larger, data set before they can be regarded 
as having been confirmed. Cloning a susceptibility gene for AS might also yield clues to the 
aetiology of the other disorders. 
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12. VIEWPOINTS   
IS THERE AN ASPERGER SYNDROME? 
Since the introduction of Asperger syndrome, discussions relating to Asperger syndrome have 
focused on its validity in relation to autism without accompanying mental retardation, HFA, and 
also in relation to other diagnostic concepts such as PDD-NOS and schizoid personality disorder. 
The tentative inclusion of Asperger syndrome in the ICD-10 and DSM-IV was guided by an 
attempt to bring Asperger syndrome to the attention of nosological investigators. Almost a decade 
later, the nosological status of Asperger syndrome is still uncertain. The studies (I-V) in this thesis 
did not necessarily make the picture clearer than before, as a marked overlap with other 
neuropsychiatric conditions with respect to clinical findings, neuroimaging and molecular genetics 
was demonstrated. At present, there are no single or any combination of measurable biological 
markers for this syndrome and the diagnosis of Asperger syndrome has to be based on a set of 
behavioural markers. The same thing applies to most other neuropsychiatric conditions. They were 
all originally defined on the basis of their behavioural or clinical characteristics. So attempts to 
identify a specific neurobiological basis for each of them probably represents a futile after-
construction.
In the case of Asperger syndrome, approaching the diagnostic dilemma by elucidating in detail the 
distribution of clinical or personality traits considered or suggested to be useful for the differential 
diagnosis not only in AS but also in other relevant disorders (i.e. autism, ADHD, schizophrenia, 
OCD, Tourette syndrome) would be a more fruitful solution. Ideally, these data would form a 
thorough basis for classifying all PDD disorders along a dimensional continuum. These data could 
only indicate whether or not the present set of historical neuropsychiatric conditions is relevant. 
The most burning questions relate to the differential diagnosis, whether or not HFA and Asperger 
syndrome are separable entities (Ghaziuddin and Gerstein 1996, Gillberg 1998, Kugler 1998, 
Baron-Cohen 2000) and it is to be hoped that they could be answered in this way. 
Neuropsychological findings do not distinguish these disorders from each other and they also 
indicate a large overlap in other features. For many practical reasons, merging Asperger syndrome 
and high-functioning autism into a single entity would be an advantage. 
PATHOGENESIS AND PROGNOSIS 
At present, virtually nothing is known about the pathogenesis. Factors of probable importance for 
the etiology have been presented, but they can only give some clues to the pathogenesis. Asperger 
syndrome does not appear to present itself in a similar manner in both sexes and in different age 
groups (Gillberg 1991, Volkmar et al. 1993, Eisenmajer et al. 1996, Nieminen et al. 2000, Ozonoff 
et al. 2000 Szatmari et al. 2000, Tantam et al. 2000, Klin and Volkmar 2003), although this has not 
been verified in longitudinal studies. This variability is apparently one explanation of the variation 
in the reported prevalences. Due to the lack of longitudinal, population-based studies, very little is 
known about the natural course or prognosis of Asperger syndrome. The very few attempts that 
have been made to analyse the prognosis have been based on selected populations and have 
produced a gloomy picture. On the other hand, there are occasional case reports in which 
successful historical persons, such as Albert Einstein, Ludwig Wittgenstein and Charles XII, have 
been considered in retrospect to represent AS (Lagerkvist 2002, Fitzgerald 2000a, Fitzgerald 
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2000b). The tentative relationship with schizophrenia is also of interest with respect to prognosis, 
as in his series Hans Asperger already had patients who also later in life were diagnosed  as having 
schizophrenia (Asperger 1944, Wolff 2000). The series of Nylander and co-workers (2001) 
showing that 3.2% of adults with psychiatric diagnoses would in retrospect have fulfilled the 
criteria for Asperger syndrome also indicates that Asperger syndrome in childhood may manifest 
as psychosis or schizophrenia in adulthood. This observation is well in line with our present results 
which demonstrate several joint biological characteristics for Asperger syndrome and 
schizophrenia. An extreme interpretation of this would indicate that Asperger syndrome or traits in 
childhood are a risk factor for developing schizophrenia or comparable psychosis in adulthood, 
although no risk analyses have been carried out. 
With respect to pathogenesis, dopamine is of special interest in this context as it is the 
neurotransmitter in the brain which has been connected with autism, schizophrenia, ADHD, 
Tourette syndrome and Parkinson's disease. Dopamine as a neurotransmitter has been implicated as 
a modulator in the brain, regulating social behaviour, perception of the outside world, motor 
activity and attention skills, all of which are to some extent abnormal in the above-mentioned 
disorders. It can be speculated that dopamine plays an important role in the psychopathology of 
Asperger syndrome or that, in all the neuropsychiatric disorders, dopamine acts as a 
neurotransmitter, resulting in a partly variable clinical picture. If the last assumption is thought to 
be the case, it means that all or many neuropsychiatric disorders represent the same continuum. 
The clinical manifestation can be dependent on a number of external factors, the impact of which is 
currently unknown.  
 75 
13. CONCLUSIONS 
The present studies were performed in Helsinki in 1998-2004 with the aim of elucidating the 
autism spectrum disorder by combining clinical data, neuroimaging, neuropsychology and 
molecular genetics.  
The present studies revealed that there are clinical features in Asperger syndrome, which are 
important in order to understand Asperger syndrome but are not currently included in the ICD-10 
and DSM-IV. Their presence indicates that aberrant processing of sensory input representing 
several modalities may be a key endophenotype in Asperger syndrome. 
The neuroimaging findings reveal a partial overlap with autism and schizophrenia in particular. 
Megaencephaly, which has been reported to be an essential feature in autism, could not be 
demonstrated in children and adults in this series of Asperger syndrome. The PET study focused on 
the Theory of Mind and identified cerebellar activation during cognitive tasks as a specific feature 
of Asperger syndrome.  
Asperger syndrome is over-represented in some families. In some families, there are also 
individuals with autism and dysphasia, but, in the majority of the studied families, only Asperger 
syndrome is present. The mode of inheritance cannot be specified at this point, but it clearly does 
not represent the recessive mode. The molecular genetic studies identify susceptibility genes 
specific to Asperger syndrome but also joint ones for autism and schizophrenia on chromosome 1. 
The set of studies included in this thesis appears to show that Asperger syndrome shares clinical, 
neuroimaging and molecular genetic findings with some other neuropsychiatric disorders and 
especially with autism and schizophrenia. This speaks in favour of the fact that these conditions 
partly exhibit similar or even identical underlying neurobiological abnormalities. These 
observations may also be of importance when it comes to understanding the pathogenesis of these 
conditions. The optimised secondary prevention, management, treatment and rehabilitation of these 
apparently related conditions should be based on a detailed knowledge of the underlying 
pathogenesis.
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Appendix I 
The complementary questions regarding symptoms and signs not included in the ICD-10 
and/or DSM-IV. The following domains were included. 
1. Presence of prosopagnosia
Do you have difficulty recognising familiar persons from their faces? 
Standardised clarifying questions were used, such as: 
If the clothing, colour of the hair of an individual familiar to you has changed or you meet 
unexpectedly in an unfamiliar place, would you be able to recognise him/her? the person any 
more? 
Do you generally recognise people on the basis of their style of walking, clothing, voice/speech 
rather than by their face? 
2. Sensibility
The aim was to find out whether the individual considered himself and/or was considered to 
represent hypo- or hyper sensibility in any mode of sensation, touch (gentle and hard), pain, 
light, external temperature, sound and smell. A fixed set of clarifying questions was used. 
3. Eating habits 
The fixed clarifying questions comprised the following items: 
unusual/odd food preferences 
unusual routines regarding arranging food on the plate and eating  
presence of aversion due to the smell of the food 
ongoing or past anorectic behaviour  
4. Diurnal rhythm/sleeping disturbances
The clarifying questions dealt with: getting to sleep, awakening during the night, amount of 
sleep, abnormality of diurnal rhythm, use of sleeping pills, restless legs, impact of possible 
difficulties of diurnal rhythm of every day life. 
5. Behaviour
The clarifying questions pinpointed the possible presence of selection difficulties in ordinary 
every day situations (ice-cream a or b). It was also established whether making up one’s mind 
in such situations leads to the avoidance of such situations or the use of clearly excessive time 
to make the decisions. Another set of questions aimed to clarify whether the individual 
him/herself recognised traits of hyperactivity and/or attention difficulties or whether other 
people had made him/her aware of such traits. 
6. External appearance
The possible presence of unusual physical features with respect to stature, flexibility of joints 
and minor stigmata was recorded. In both genders, the questions were designed to determine 
whether the individual was frequently wrongly perceived with respect to chronological age. 
Moreover, the interviewer’s perception of a possible youthful appearance was recorded. In 
males, questions also focused on the age at which regular shaving began and the maximum 
interval between shavings, which was compatible with socially acceptable tidiness of the face. 
Answers reporting this shaving less frequently than twice a week were considered to be outside 
the average range for adult Finnish men. 
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